Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2324431 | 0.89 | HPRT1 (0.48) | ALDH1A1CYP1A2CYP2C9CYP2C19LMNA | |
| SCHEMBL2327935 | 0.83 | ALDH1A1 (0.40) | ALDH1A1CYP1A2CYP2C9CYP2C19GAA | |
| SCHEMBL10399086 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL1306447 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL6005210 | 0.79 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL1199042 | 0.79 | ALDH1A1 (0.58) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL27450400 | 0.78 | ALDH1A1 (0.48) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL367155 | 0.77 | ALDH1A1 (0.47) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL25887 | 0.77 | ALDH1A1 (0.47) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL27548 | 0.77 | ALDH1A1 (0.61) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 991 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580795-B2 | Heterocyclic compounds as phosphodiesterase inhibitors | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2013-11-12 | — | — | US | claimed |
| US-20120277164-A1 | GADD45BETA TARGETING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2012-11-01 | — | — | US | claimed |
| EP-2491051-A2 | GADD45BETA TARGETING AGENTS | Imperial Innovations Limited (GB) | 2012-08-29 | — | — | EP | claimed |
| US-20110269753-A1 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2011-11-03 | — | — | US | claimed |
| EP-2379538-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | Orchid Research Laboratories Limited (IN) | 2011-10-26 | — | — | EP | claimed |
| WO-2011048390-A2 | GADD45BETA TARGETING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2011-04-28 | — | — | WO | claimed |
| WO-2010084402-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2010-07-29 | — | — | WO | claimed |
| US-7375081-B2 | Therapeutic combination of a pneumocandin derivative and an antifungal agent | ASTELLAS PHARMA INC. (JP) | 2008-05-20 | — | — | US | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-0668874-B1 | LHRH ANTAGONISTS AND INTERMEDIATE PRODUCTS | SCHERING AG (DE) | 1998-08-26 | — | — | EP | claimed |
| US-5527777-A | TREATMENT OF PROSTATE CANCER, ANTIFERTILITY AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-06-18 | — | — | US | claimed |
| US-5140009-A | Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders | TAP PHARMACEUTICALS, INC. (US) | 1992-08-18 | — | — | US | claimed |
| EP-0480918-A1 | REDUCED SIZE LHRH ANALOGS | ABBOTT LABORATORIES (US) | 1992-04-22 | — | — | EP | claimed |
| EP-0480918-A4 | REDUCED SIZE LHRH ANALOGS. | ABBOTT LAB (US) | 1991-06-04 | — | — | EP | claimed |
| EP-0417454-A2 | Reduced size LHRH analogs | ABBOTT LABORATORIES (US) | 1991-03-20 | — | — | EP | claimed |
| WO-1989007451-A1 | REDUCED SIZE LHRH ANALOGS | ABBOTT LABORATORIES (US) | 1989-08-24 | — | — | WO | claimed |
| EP-0328089-A2 | Reduced size LHRH analogs | ABBOTT LABORATORIES (US) | 1989-08-16 | — | — | EP | claimed |
| US-20240084308-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2024-03-14 | — | — | US | disclosed |
| US-20240034845-A1 | POLYMER PARTICLES | QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) | 2024-02-01 | — | — | US | disclosed |
| EP-3384549-B1 | SODIUM-ION ELECTROLYTE COMPOSITION | UNIV DEAKIN (AU) | 2024-01-17 | — | — | EP | disclosed |
| CN-111615517-B | YEATS inhibitors and methods of use thereof | 香港大学 | 2024-01-09 | — | — | CN | disclosed |
| US-11834663-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2023-12-05 | — | — | US | disclosed |
| US-20230348674-A1 | HYDROGELS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-11-02 | — | — | US | disclosed |
| CN-113939544-B | non-core-shell polymer particles | 悉尼大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-116615468-A | Polymer particles | 昆士兰科技大学 | 2023-08-18 | — | — | CN | disclosed |
| EP-4225811-A1 | POLYMER PARTICLES | Queensland University Of Technology (AU) | 2023-08-16 | — | — | EP | disclosed |
| CN-116406421-A | Immune cell culture method and application thereof | 苏州沙砾生物科技有限公司 | 2023-07-07 | — | — | CN | disclosed |
| WO-2023121483-A1 | IMMUNOSTIMULATORY COMPOSITIONS | VICTORIA LINK LIMITED (NZ) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023102600-A1 | SYNTHESIS OF AMPHIPHILIC BLOCK COPOLYMERS AND POLYMERIC NANOFIBERS PRODUCED THEREFROM | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023099589-A1 | IRAP INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
| US-20230143246-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-11 | — | — | US | disclosed |
| EP-4172272-A1 | HYDROGELS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2023-05-03 | — | — | EP | disclosed |
| US-20230088365-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-03-23 | — | — | US | disclosed |
| US-20230091115-A1 | CROSSLINKABLE POLYSILOXANE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-03-23 | — | — | US | disclosed |
| WO-2023284721-A1 | METHOD FOR CULTURING IMMUNE CELL AND USE THEREOF | 苏州沙砾生物科技有限公司 | 2023-01-19 | — | — | WO | disclosed |
| EP-4093807-A1 | CROSSLINKABLE POLYSILOXANE | Commonwealth Scientific and Industrial Research Organisation (AU) | 2022-11-30 | — | — | EP | disclosed |
| CN-114835619-A | Process for preparing azole compounds | 武田药品工业株式会社 | 2022-08-02 | — | — | CN | disclosed |
| CN-110200903-B | Liquid formulations of amines and organic acids stabilized with salts | 武田药品工业株式会社 | 2022-07-29 | — | — | CN | disclosed |
| US-20220177659-A1 | NON-CORE SHELL POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2022-06-09 | — | — | US | disclosed |
| US-20220126270-A1 | CAPTURE OF FLUORINATED CARBON COMPOUNDS | THE UNIVERSITY OF QUEENSLAND (AU) | 2022-04-28 | — | — | US | disclosed |
| EP-3947476-A1 | NON-CORE-SHELL POLYMER PARTICLES | The University of Sydney (AU) | 2022-02-09 | — | — | EP | disclosed |
| CN-113939544-A | Non-core-shell polymer particles | 悉尼大学 | 2022-01-14 | — | — | CN | disclosed |
| WO-2021261471-A1 | THERAPEUTIC AGENT FOR OBSESSIVE-COMPULSIVE DISORDER | 国立大学法人京都大学 | 2021-12-30 | — | — | WO | disclosed |
| WO-2021258147-A1 | HYDROGELS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2021-12-30 | — | — | WO | disclosed |
| EP-3929187-A2 | PROCESS FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2021-12-29 | — | — | EP | disclosed |
| EP-3921080-A1 | CAPTURE OF FLUORINATED CARBON COMPOUNDS | The University of Queensland (AU) | 2021-12-15 | — | — | EP | disclosed |
| US-20210340547-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2021-11-04 | — | — | US | disclosed |
| US-11078488-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2021-08-03 | — | — | US | disclosed |
| WO-2021146773-A1 | CROSSLINKABLE POLYSILOXANE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2021-07-29 | — | — | WO | disclosed |
| US-10957938-B2 | Sodium-ion electrolyte composition | DEAKIN UNIVERSITY (AU) | 2021-03-23 | — | — | US | disclosed |
| US-20210070705-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-03-11 | — | — | US | disclosed |
| US-10844011-B2 | Process for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-11-24 | — | — | US | disclosed |
| US-20200362354-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2020-11-19 | — | — | US | disclosed |
| WO-2020198789-A1 | NON-CORE-SHELL POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2020-10-08 | — | — | WO | disclosed |
| CN-107531624-B | Pyrrolidine compounds | 住友化学株式会社 | 2020-10-02 | — | — | CN | disclosed |
| US-10787668-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2020-09-29 | — | — | US | disclosed |
| CN-101693736-B | Novel peptides | 寒川贤治 | 2020-09-11 | — | — | CN | disclosed |
| CN-111615517-A | YEATS inhibitors and methods of use thereof | 香港大学 | 2020-09-01 | — | — | CN | disclosed |
| WO-2020160626-A1 | CAPTURE OF FLUORINATED CARBON COMPOUNDS | THE UNIVERSITY OF QUEENSLAND (AU) | 2020-08-13 | — | — | WO | disclosed |
| EP-2963019-B1 | METHOD FOR PRODUCING PYRIDINE-3-SULFONYL CHLORIDE | TAKEDA PHARMACEUTICALS CO (JP) | 2020-08-12 | — | — | EP | disclosed |
| EP-3328384-B1 | FIBROTIC TREATMENT | UNIV MONASH (AU) | 2020-07-29 | — | — | EP | disclosed |
| US-10697019-B2 | Method of diagnosis and prognosis | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2020-06-30 | — | — | US | disclosed |
| US-20200115336-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2020-04-16 | — | — | US | disclosed |
| CN-110917130-A | Liquid formulations of amines and organic acids stabilized with salts | 武田药品工业株式会社 | 2020-03-27 | — | — | CN | disclosed |
| US-20200093852-A1 | Methods of Treating Ocular Disorders | Beta Therapeutics Pty Ltd (AU) | 2020-03-26 | — | — | US | disclosed |
| EP-3613734-A2 | PROCESS FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2020-02-26 | — | — | EP | disclosed |
| EP-3559120-A1 | AQUEOUS POLYMER COMPOSITION | Commonwealth Scientific and Industrial Research Organisation (AU) | 2019-10-30 | — | — | EP | disclosed |
| EP-3241826-B1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2019-10-30 | — | — | EP | disclosed |
| EP-3554505-A1 | METHODS OF TREATING OCULAR DISORDERS | Beta Therapeutics Pty. Ltd. (AU) | 2019-10-23 | — | — | EP | disclosed |
| US-10439252-B2 | Electrolyte solution for electrochemical device, and electrochemical device | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-08 | — | — | US | disclosed |
| US-20190269718-A1 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2019-09-05 | — | — | US | disclosed |
| US-20190249179-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2019-08-15 | — | — | US | disclosed |
| US-10370357-B2 | Method for producing sulfonyl chloride compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2019-08-06 | — | — | US | disclosed |
| US-10308605-B2 | Proton pump inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20190127324-A1 | 5-ARYL-1H-PYRROLE-3-CARBONITRILE AND A PHARMACEUTICAL PRODUCT USING THE SAME | TAKEDA PHARMACEUTICALS CO (JP) | 2019-05-02 | — | — | US | disclosed |
| EP-3287440-B1 | PYRROLIDINE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2019-03-27 | — | — | EP | disclosed |
| US-10173977-B2 | 5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2019-01-08 | — | — | US | disclosed |
| US-20180358654-A1 | SODIUM-ION ELECTROLYTE COMPOSITION | MONASH UNIVERSITY (AU) | 2018-12-13 | — | — | US | disclosed |
| US-20180344763-A1 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-12-06 | — | — | US | disclosed |
| EP-2340271-B1 | POLYMER-BIOACTIVE AGENT CONJUGATES | POLYACTIVA PTY LTD (AU) | 2018-12-05 | — | — | EP | disclosed |
| US-20180327519-A1 | AMPHIPHILIC RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2018-11-15 | — | — | US | disclosed |
| EP-2363419-B1 | Polymer product formed using raft agent | UNIV SYDNEY (AU) | 2018-11-14 | — | — | EP | disclosed |
| US-10100311-B2 | Fibrotic treatment | MONASH UNIVERSITY (AU) | 2018-10-16 | — | — | US | disclosed |
| EP-3384549-A1 | SODIUM-ION ELECTROLYTE COMPOSITION | Deakin University (AU) | 2018-10-10 | — | — | EP | disclosed |
| CN-105510263-B | A kind of HPLC analysis methods of 3- amino piperidines isomers | 河北科技大学 | 2018-08-31 | — | — | CN | disclosed |
| US-10059796-B2 | Conjugated polymers | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-08-28 | — | — | US | disclosed |
| US-20180223287-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2018-08-09 | — | — | US | disclosed |
| US-10040760-B2 | Pyrrolidine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-08-07 | — | — | US | disclosed |
| US-10029207-B2 | Composite gas separation membrane | THE UNIVERSITY OF MELBOURNE (AU) | 2018-07-24 | — | — | US | disclosed |
| EP-3004239-B1 | SCRATCH RESISTANT POLYMERS | TENASITECH PTY LTD (AU) | 2018-07-18 | — | — | EP | disclosed |
| EP-1463765-B1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIV SYDNEY (AU) | 2018-07-18 | — | — | EP | disclosed |
| EP-3341421-A1 | AMPHIPHILIC RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2018-07-04 | — | — | EP | disclosed |
| WO-2018112555-A1 | AQUEOUS POLYMER COMPOSITION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-06-28 | — | — | WO | disclosed |
| US-20180170905-A1 | Method for Producing Sulfonyl Chloride Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-06-21 | — | — | US | disclosed |
| WO-2018107226-A1 | METHODS OF TREATING OCULAR DISORDERS | Beta Therapeutics Pty. Ltd. (AU) | 2018-06-21 | — | — | WO | disclosed |
| EP-2001911-B1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | UNIV SYDNEY (AU) | 2018-06-13 | — | — | EP | disclosed |
| EP-3328384-A1 | FIBROTIC TREATMENT | Monash University (AU) | 2018-06-06 | — | — | EP | disclosed |
| US-20180148446-A1 | PYRROLO [2,3-c] PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE | TAKEDA PHARMACEUTICALS CO (JP) | 2018-05-31 | — | — | US | disclosed |
| US-20180141912-A1 | VERSATILE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-05-24 | — | — | US | disclosed |
| US-9968684-B2 | Polymer-NSAID conjugate | POLYACTIVA PTY LTD (AU) | 2018-05-15 | — | — | US | disclosed |
| US-20180127364-A1 | PYRROLIDINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-10 | — | — | US | disclosed |
| EP-2863921-B1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2018-04-18 | — | — | EP | disclosed |
| EP-3307716-A1 | VERSATILE RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2018-04-18 | — | — | EP | disclosed |
| US-9932322-B2 | Method for producing sulfonyl chloride compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-04-03 | — | — | US | disclosed |
| EP-3287440-A1 | PYRROLIDINE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-20180009746-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2018-01-11 | — | — | US | disclosed |
| EP-3265143-A1 | METHODS FOR ADVERSELY AFFECTING BIOFILMS | Commonwealth Scientific & Industrial Research Organisation ( C.S.I.R.O. ) (AU) | 2018-01-10 | — | — | EP | disclosed |
| US-9828351-B2 | Enzyme interacting agents | MONASH UNIVERSITY (AU) | 2017-11-28 | — | — | US | disclosed |
| US-20170333942-A1 | POLYMERISATION PROCESS AND POLYMER PRODUCT | THE UNIVERSITY OF SYDNEY (AU) | 2017-11-23 | — | — | US | disclosed |
| EP-3241826-A2 | PROCESS FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2017-11-08 | — | — | EP | disclosed |
| US-20170298026-A1 | ALL PURPOSE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-10-19 | — | — | US | disclosed |
| EP-2738170-B1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2017-08-30 | — | — | EP | disclosed |
| US-20170240592-A1 | GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2017-08-24 | — | — | US | disclosed |
| EP-3204353-A1 | ALL PURPOSE RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-08-16 | — | — | EP | disclosed |
| US-9731321-B2 | Polymerisation process and polymer product | THE UNIVERSITY OF SYDNEY (AU) | 2017-08-15 | — | — | US | disclosed |
| US-20170216765-A1 | COMPOSITE GAS SEPARATION MEMBRANE | THE UNIVERSITY OF MELBOURNE (AU) | 2017-08-03 | — | — | US | disclosed |
| EP-2765130-B1 | Intermediates for use in a process of producing pyrrole compounds | TAKEDA PHARMACEUTICALS CO (JP) | 2017-07-26 | — | — | EP | disclosed |
| US-20170190698-A1 | ENZYME INTERACTING AGENTS | CENTRAL ADELAIDE LOCAL HEALTH NETWORK INCORPORATED (AU) | 2017-07-06 | — | — | US | disclosed |
| EP-3180350-A1 | GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY | Imperial Innovations Ltd (GB) | 2017-06-21 | — | — | EP | disclosed |
| EP-3178836-A1 | GADD45BETA TARGETING AGENTS | Imperial Innovations Limited (GB) | 2017-06-14 | — | — | EP | disclosed |
| WO-2017091854-A1 | SODIUM-ION ELECTROLYTE COMPOSITION | DEAKIN UNIVERSITY (AU) | 2017-06-08 | — | — | WO | disclosed |
| US-9663634-B2 | Scratch resistant polymers | TENASITECH PTY LTD (AU) | 2017-05-30 | — | — | US | disclosed |
| US-9650450-B2 | RAFT polymers | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-05-16 | — | — | US | disclosed |
| EP-3162798-A1 | 5-MEMBERED HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2017-05-03 | — | — | EP | disclosed |
| EP-3160949-A1 | ENZYME INTERACTING AGENTS | Monash University (AU) | 2017-05-03 | — | — | EP | disclosed |
| EP-2791184-B1 | PROCESS FOR REMOVING THIOCARBONYLTHIO GROUPS FROM RAFT POLYMERS | COMMW SCIENT IND RES ORG (AU) | 2017-04-19 | — | — | EP | disclosed |
| US-9617277-B2 | Polymeric materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-04-11 | — | — | US | disclosed |
| EP-2389395-B1 | RAFT POLYMERISATION | COMMW SCIENT IND RES ORG (AU) | 2017-03-29 | — | — | EP | disclosed |
| US-9606440-B2 | Lithographically produced features | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-03-28 | — | — | US | disclosed |
| WO-2017035570-A1 | AMPHIPHILIC RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-03-09 | — | — | WO | disclosed |
| US-9587104-B2 | Release media | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-03-07 | — | — | US | disclosed |
| WO-2017015720-A1 | FIBROTIC TREATMENT | MONASH UNIVERSITY (AU) | 2017-02-02 | — | — | WO | disclosed |
| EP-2288374-B1 | NOVEL N-AND C-TERMINAL SUBSTITUTED ANTAGONISTIC ANALOGS OF HUMAN GH-RH | THE UNIV OF MIAMI (US) | 2017-02-01 | — | — | EP | disclosed |
| EP-3121208-A1 | POLYMERIC MATERIALS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-01-25 | — | — | EP | disclosed |
| US-20170008874-A1 | Method for Producing Sulfonyl Chloride Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-01-12 | — | — | US | disclosed |
| EP-2702167-B1 | METHODS OF DIAGNOSIS AND PROGNOSIS OF MULTIPLE MYELOMA, BY MEASURING GADD45BETA EXPRESSION | IMP INNOVATIONS LTD (GB) | 2016-12-28 | — | — | EP | disclosed |
| WO-2016197187-A1 | VERSATILE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-12-15 | — | — | WO | disclosed |
| US-9518083-B2 | Gadd45beta targeting agents | IMPERIAL INNOVATIONS LIMITED (GB) | 2016-12-13 | — | — | US | disclosed |
| EP-2355853-B1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | POLYACTIVA PTY LTD (AU) | 2016-12-07 | — | — | EP | disclosed |
| US-9493419-B2 | Quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2016-11-15 | — | — | US | disclosed |
| US-9487485-B2 | Method for producing sulfonyl chloride compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-11-08 | — | — | US | disclosed |
| US-20160303243-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES LLC (US) | 2016-10-20 | — | — | US | disclosed |
| EP-2507280-B1 | POLYMERIC MATERIALS | COMMW SCIENT IND RES ORG (AU) | 2016-10-19 | — | — | EP | disclosed |
| EP-2402313-B1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-9408919-B2 | Biodegradable polymer—bioactive moiety conjugates | POLYACTIVA PTY LTD. (AU) | 2016-08-09 | — | — | US | disclosed |
| US-20160194439-A1 | CONJUGATED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-07-07 | — | — | US | disclosed |
| US-20160166652-A1 | NOVEL N- AND C-TERMINAL SUBSTITUTED ANTAGONISTIC ANALOGS OF GH-RH | UNIV MIAMI (US) | 2016-06-16 | — | — | US | disclosed |
| US-9346845-B2 | Anionic conjugates of glycosylated bacterial metabolite | GLYCAN BIOSCIENCES LLC (US) | 2016-05-24 | — | — | US | disclosed |
| US-9340498-B2 | Raft polymerisation | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESERACH ORGANISATION (AU) | 2016-05-17 | — | — | US | disclosed |
| US-9339781-B2 | Polymer particles | THE UNIVERSITY OF SYDNEY (AU) | 2016-05-17 | — | — | US | disclosed |
| US-20160122514-A1 | SCRATCH RESISTANT POLYMERS | MILLER WASTE MILLS INC. DBA RTP COMPANY | 2016-05-05 | — | — | US | disclosed |
| US-9321730-B2 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2016-04-26 | — | — | US | disclosed |
| WO-2016054689-A1 | ALL PURPOSE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-04-14 | — | — | WO | disclosed |
| EP-3004239-A1 | SCRATCH RESISTANT POLYMERS | Tenasitech Pty Ltd. (AU) | 2016-04-13 | — | — | EP | disclosed |
| US-9302993-B2 | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2016-04-05 | — | — | US | disclosed |
| US-20160075716-A1 | POLYMERIC MATERIALS | COMMONWEALTH SCIENTIFIC INDUSTRIAL AND RESEARCH ORGANISATION (AU) | 2016-03-17 | — | — | US | disclosed |
| EP-2619232-B1 | CONTINUOUS FLOW POLYMERISATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2016-03-16 | — | — | EP | disclosed |
| US-20160052925-A1 | METHOD OF TREATMENT OR PROPHYLAXIS INFTAMMATORY PAIN | NOVARTIS AG (CH) | 2016-02-25 | — | — | US | disclosed |
| US-9266831-B2 | Process for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-02-23 | — | — | US | disclosed |
| WO-2016024131-A1 | GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY | IMPERIAL INNOVATIONS LIMITED (GB) | 2016-02-18 | — | — | WO | disclosed |
| US-9260504-B2 | N- and C-terminal substituted antagonistic analogs of GH-RH | UNIVERSITY OF MIAMI (US) | 2016-02-16 | — | — | US | disclosed |
| US-9255198-B2 | Water swellable polymer materials comprising particulate core and water swellable R.A.F.T polymer shell | THE UNIVERSITY OF SYDNEY (AU) | 2016-02-09 | — | — | US | disclosed |
| US-20160015786-A1 | MOBILIZING AGENTS AND USES THEREFOR | MATER MEDICAL RESEARCH INSTITUTE LIMITED (AU) | 2016-01-21 | — | — | US | disclosed |
| US-20160009646-A1 | METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-01-14 | — | — | US | disclosed |
| US-20160004163-A1 | LITHOGRAPHICALLY PRODUCED FEATURES | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-01-07 | — | — | US | disclosed |
| EP-2963019-A1 | METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2016-01-06 | — | — | EP | disclosed |
| US-9227968-B2 | Method of treatment or prophylaxis of inflammatory pain | NOVARTIS AG (CH) | 2016-01-05 | — | — | US | disclosed |
| WO-2015196258-A1 | ENZYME INTERACTING AGENTS | MONASH UNIVERSITY (AU) | 2015-12-30 | — | — | WO | disclosed |
| US-20150368294-A1 | GADD45BETA TARGETING AGENTS | IP2IPO INNOVATIONS LIMITED (GB) | 2015-12-24 | — | — | US | disclosed |
| WO-2015192175-A1 | POLYMER HYDROGEL | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-12-23 | — | — | WO | disclosed |
| US-20150364792-A1 | ELECTROLYTE SOLUTION FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
| US-9212257-B2 | Polymeric materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-12-15 | — | — | US | disclosed |
| EP-2952185-A1 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFLAMMATORY PAIN | Spinifex Pharmaceuticals Pty Ltd (AU) | 2015-12-09 | — | — | EP | disclosed |
| US-20150335635-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-11-26 | — | — | US | disclosed |
| US-20150337128-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-11-26 | — | — | US | disclosed |
| US-9186411-B2 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-11-17 | — | — | US | disclosed |
| US-9169211-B2 | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-10-27 | — | — | US | disclosed |
| US-9156837-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-10-13 | — | — | US | disclosed |
| EP-2336107-B1 | Proton pump inhibitors | TAKEDA PHARMACEUTICAL (JP) | 2015-09-23 | — | — | EP | disclosed |
| US-20150165027-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20150166617-A1 | COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE | THE UNIVERSITY OF MIAMI | 2015-06-18 | — | — | US | disclosed |
| US-20150150999-A1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2015-06-04 | — | — | US | disclosed |
| EP-2866788-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | Takeda Pharmaceutical Company Limited (JP) | 2015-05-06 | — | — | EP | disclosed |
| EP-2866894-A2 | COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE | The University Of Miami (US) | 2015-05-06 | — | — | EP | disclosed |
| EP-2863921-A1 | POLYMER-NSAID CONJUGATE | Polyactiva Pty Ltd (AU) | 2015-04-29 | — | — | EP | disclosed |
| US-9018207-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2015-04-28 | — | — | US | disclosed |
| EP-2859088-A1 | RELEASE MEDIA | The University Of Queensland (AU) | 2015-04-15 | — | — | EP | disclosed |
| US-20150094334-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-04-02 | — | — | US | disclosed |
| US-8993717-B2 | Gadd45beta targeting agents | IMPERIAL INNOVATIONS LIMITED (GB) | 2015-03-31 | — | — | US | disclosed |
| US-8993697-B2 | Conducting and semiconducting organic materials | Commonwealth Scientific and Industrial Research Institute Organisation (AU) | 2015-03-31 | — | — | US | disclosed |
| US-8975278-B2 | 8-hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-03-10 | — | — | US | disclosed |
| WO-2015013747-A1 | CONJUGATED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-02-05 | — | — | WO | disclosed |
| US-8946360-B2 | Continuous flow polymerisation process | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-02-03 | — | — | US | disclosed |
| US-20150024488-A1 | NUCLEIC ACID COMPLEX | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2015-01-22 | — | — | US | disclosed |
| US-20150025108-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2015-01-22 | — | — | US | disclosed |
| US-8933105-B2 | Pyrrole compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-01-13 | — | — | US | disclosed |
| US-8932806-B1 | Method for identifying t-cell stimulating protein fragments | KERN FLORIAN (DE) | 2015-01-13 | — | — | US | disclosed |
| WO-2014205512-A1 | NOVEL POLYMERS AND THEIR USE IN ORGANIC PHOTOVOLTAICS | THE UNIVERSITY OF MELBOURNE (AU) | 2014-12-31 | — | — | WO | disclosed |
| WO-2014194380-A1 | SCRATCH RESISTANT POLYMERS | TENASITECH PTY LTD (AU) | 2014-12-11 | — | — | WO | disclosed |
| WO-2014190398-A1 | INHIBITION OF AMYLOID FIBRIL FORMATION | THE UNIVERSITY OF MELBOURNE (AU) | 2014-12-04 | — | — | WO | disclosed |
| US-20140350182-A1 | RAFT POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2014-11-27 | — | — | US | disclosed |
| EP-1720889-B1 | SULFATED OLIGOSACCHARIDE DERIVATIVES | PROGEN PHARMACEUTICALS LTD (AU) | 2014-11-26 | — | — | EP | disclosed |
| US-20140343070-A1 | PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-11-20 | — | — | US | disclosed |
| EP-2271624-B9 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2014-11-12 | — | — | EP | disclosed |
| US-20140329932-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2014-11-06 | — | — | US | disclosed |
| US-20140323422-A1 | Anionic Conjugates of Glycosylated Bacterial Metabolite | Glycosynnovations Pty Ltd (AU) | 2014-10-30 | — | — | US | disclosed |
| EP-2791184-A1 | RAFT POLYMERS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2014-10-22 | — | — | EP | disclosed |
| US-20140303378-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL (JP) | 2014-10-09 | — | — | US | disclosed |
| US-8852641-B2 | Polymer microgel beads and preparative method thereof | THE UNIVERSITY OF SYDNEY (AU) | 2014-10-07 | — | — | US | disclosed |
| US-8822694-B2 | Process for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-09-02 | — | — | US | disclosed |
| WO-2014127430-A1 | LITHOGRAPHICALLY PRODUCED FEATURES | THE UNIVERSITY OF QUEENSLAND (AU) | 2014-08-28 | — | — | WO | disclosed |
| EP-2478011-B1 | FLUORINATED GHRH ANTAGONISTS | UNIV MIAMI (US) | 2014-08-27 | — | — | EP | disclosed |
| US-20140228362-A1 | Method of Treatment or Prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2014-08-14 | — | — | US | disclosed |
| EP-2765130-A2 | Process for producing pyrrole compound | Takeda Pharmaceutical Company Limited (JP) | 2014-08-13 | — | — | EP | disclosed |
| US-20140221455-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | Verva Pharmaceuticals, Inc. (AU) | 2014-08-07 | — | — | US | disclosed |
| US-8796359-B2 | Polymer product and interfacial polymerisation process using raft agent | THE UNIVERSITY OF SYDNEY (AU) | 2014-08-05 | — | — | US | disclosed |
| US-8791245-B2 | Anionic conjugates of glycosylated bacterial metabolite | Glycan Bioscience LLC (US) | 2014-07-29 | — | — | US | disclosed |
| US-20140206836-A1 | NOVEL N- AND C-TERMINAL SUBSTITUTED ANTAGONISTIC ANALOGS OF GH-RH | U.S.A., REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2014-07-24 | — | — | US | disclosed |
| EP-2291175-B1 | ADMINISTRABLE COMPOSITIONS | UNIV SYDNEY (AU) | 2014-07-23 | — | — | EP | disclosed |
| US-8779029-B2 | Polymer product and interfacial polymerisation process using raft agent | THE UNIVERSITY OF SYDNEY (AU) | 2014-07-15 | — | — | US | disclosed |
| WO-2014066936-A9 | SUPRAMOLECULAR STRUCTURE | MONASH UNIVERSITY (AU) | 2014-07-10 | — | — | WO | disclosed |
| US-8765183-B2 | Polymer microgel beads | THE UNIVERSITY OF SYDNEY (AU) | 2014-07-01 | — | — | US | disclosed |
| US-20140163001-A1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-06-12 | — | — | US | disclosed |
| EP-2327692-B9 | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | TAKEDA PHARMACEUTICAL (JP) | 2014-06-04 | — | — | EP | disclosed |
| EP-2738170-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2014-06-04 | — | — | EP | disclosed |
| US-8735097-B2 | Human antibiotic proteins | PLANTON GMBH (DE) | 2014-05-27 | — | — | US | disclosed |
| US-20140142116-A1 | Method of Treatment or Prophylaxis of Inflammatory Pain | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2014-05-22 | — | — | US | disclosed |
| EP-2271624-B1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2014-05-21 | — | — | EP | disclosed |
| EP-2729182-A1 | NUCLEIC ACID COMPLEX | Commonwealth Scientific and Industrial Research Organisation (AU) | 2014-05-14 | — | — | EP | disclosed |
| US-8722675-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2014-05-13 | — | — | US | disclosed |
| WO-2014066936-A1 | SUPRAMOLECULAR STRUCTURE | MONASH UNIVERSITY (AU) | 2014-05-08 | — | — | WO | disclosed |
| US-20140128330-A1 | METHOD OF DIAGNOSIS AND PROGNOSIS | IMPERIAL INNOVATIONS LIMITED (GB) | 2014-05-08 | — | — | US | disclosed |
| US-20140120058-A1 | POLYMER CONJUGATED PROSTAGLANDIN ANALOGUES | POLYACTIVA PTY LTD | 2014-05-01 | — | — | US | disclosed |
| US-8709486-B2 | Administrable compositions | THE UNIVERSITY OF SYDNEY (AU) | 2014-04-29 | — | — | US | disclosed |
| EP-2044026-B1 | METHOD OF TREATMENT OF GLIOMA BRAIN TUMOUR | PRANA BIOTECHNOLOGY LTD (AU) | 2014-03-26 | — | — | EP | disclosed |
| EP-2702167-A2 | METHOD OF DIAGNOSIS AND PROGNOSIS | Imperial Innovations Limited (GB) | 2014-03-05 | — | — | EP | disclosed |
| EP-2696899-A1 | POLYMER CONJUGATED PROSTAGLANDIN ANALOGUES | Polyactiva Pty Ltd (AU) | 2014-02-19 | — | — | EP | disclosed |
| US-20140046018-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | POLYACTIVA PTY LTD. (AU) | 2014-02-13 | — | — | US | disclosed |
| US-20140031376-A1 | IMINOPROPENE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-01-30 | — | — | US | disclosed |
| EP-2285881-B1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | UNIV SYDNEY (AU) | 2014-01-22 | — | — | EP | disclosed |
| WO-2014003199-A1 | LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-01-03 | — | — | WO | disclosed |
| WO-2014000033-A1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2014-01-03 | — | — | WO | disclosed |
| WO-2014004934-A2 | COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE | UNIVERSITY OF MIAMI (US) | 2014-01-03 | — | — | WO | disclosed |
| US-8618329-B2 | Iminopropene compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-12-31 | — | — | US | disclosed |
| US-8617560-B2 | Peptides for vaccination against human CMV | KERN 1 PATENTE GMBH (DE) | 2013-12-31 | — | — | US | disclosed |
| WO-2013181713-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-12-12 | — | — | WO | disclosed |
| EP-1755373-B2 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2013-11-27 | — | — | EP | disclosed |
| US-8580795-B2 | Heterocyclic compounds as phosphodiesterase inhibitors | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2013-11-12 | — | — | US | disclosed |
| US-20130296350-A1 | Method of Treatment or Prophylaxis | NOVARTIS AG (CH) | 2013-11-07 | — | — | US | disclosed |
| US-20130289217-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-10-31 | — | — | US | disclosed |
| EP-2650011-A1 | Method of treatment or prophylaxis | Spinifex Pharmaceuticals Pty Ltd (AU) | 2013-10-16 | — | — | EP | disclosed |
| EP-2650010-A1 | Method of treatment or prophylaxis | Spinifex Pharmaceuticals Pty Ltd (AU) | 2013-10-16 | — | — | EP | disclosed |
| US-8557737-B2 | Methods of altering poppy characteristics | GlaxoSmithKline Australia, Pty, Ltd (AU) | 2013-10-15 | — | — | US | disclosed |
| US-8551950-B2 | Method of treatment or prophylaxis of inflammatory pain | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2013-10-08 | — | — | US | disclosed |
| US-20130261156-A1 | PHARMACEUTICAL COMPOSITION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-10-03 | — | — | US | disclosed |
| US-20130261055-A1 | Novel N- and C- terminal substituted antagonistic analogs of GH-RH | MIAMI, UNIVERSITY OF | 2013-10-03 | — | — | US | disclosed |
| US-8535655-B2 | Biodegradable polymer—bioactive moiety conjugates | POLYACTIVA PTY LTD. (AU) | 2013-09-17 | — | — | US | disclosed |
| US-20130217726-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | ST. VINCENT'S INSTITUTE OF MEDICAL RESEARCH (AU) | 2013-08-22 | — | — | US | disclosed |
| US-20130217841-A1 | CONTINUOUS FLOW POLYMERISATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-08-22 | — | — | US | disclosed |
| US-8501889-B2 | Conducting and semiconducting organic materials | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-08-06 | — | — | US | disclosed |
| EP-2619232-A1 | CONTINUOUS FLOW POLYMERISATION PROCESS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2013-07-31 | — | — | EP | disclosed |
| US-8492382-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2013-07-23 | — | — | US | disclosed |
| US-8481569-B2 | Iminopyridine derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-07-09 | — | — | US | disclosed |
| WO-2013086585-A1 | RAFT POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-06-20 | — | — | WO | disclosed |
| US-20130150392-A1 | IMINOPROPENE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-06-13 | — | — | US | disclosed |
| US-20130136848-A1 | POLYMERISATION PROCESS AND POLYMER PRODUCT | THE UNIVERSITY OF SYDNEY (AU) | 2013-05-30 | — | — | US | disclosed |
| EP-1830869-B1 | METHOD OF TREATMENT OR PROPHYLAXIS | SPINIFEX PHARM PTY LTD (AU) | 2013-05-22 | — | — | EP | disclosed |
| WO-2013067579-A1 | ADIPOSITY-MODULATING MOLECULES AND USES THEREFOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-05-16 | — | — | WO | disclosed |
| US-8436187-B2 | 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20130087736-A1 | WATER SWELLABLE POLYMER MATERIALS | THE UNIVERSITY OF SYDNEY (AU) | 2013-04-11 | — | — | US | disclosed |
| US-8415368-B2 | Acid secretion inhibitor | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-04-09 | — | — | US | disclosed |
| US-8410316-B2 | Iminopropene compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8404686-B2 | Method of treatment or prophylaxis | SPINIFEX PHARMACEUTICALS PTY LTD (AU) | 2013-03-26 | — | — | US | disclosed |
| US-20130068294-A1 | DYE-SENSITISED SOLAR CELL WITH NICKEL CATHODE | Commwealth Scientific and Industrial Reseach Organisation | 2013-03-21 | — | — | US | disclosed |
| EP-2285882-B1 | POLYMER MICROGEL BEADS | UNIV SYDNEY (AU) | 2013-03-20 | — | — | EP | disclosed |
| EP-2564833-A1 | Photostabilized pharmaceutical composition | Takeda Pharmaceutical Company Limited (JP) | 2013-03-06 | — | — | EP | disclosed |
| US-8377851-B2 | Method of altering the alkaloid composition in poppy plants | GLAXOSMITHKLINE AUSTRALIA PTY. LTD. (AU) | 2013-02-19 | — | — | US | disclosed |
| US-8377963-B2 | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof | HOWARD FLOREY INSTITUTE (AU) | 2013-02-19 | — | — | US | disclosed |
| EP-2553518-A1 | DYE-SENSITISED SOLAR CELL WITH NICKEL CATHODE | The University Of Melbourne (AU) | 2013-02-06 | — | — | EP | disclosed |
| EP-1802662-B1 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | UNIV SYDNEY (AU) | 2013-01-23 | — | — | EP | disclosed |
| WO-2013003887-A1 | NUCLEIC ACID COMPLEX | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2013-01-10 | — | — | WO | disclosed |
| EP-1803709-B1 | PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-8338462-B2 | 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) | 2012-12-25 | — | — | US | disclosed |
| US-8338461-B2 | 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-12-25 | — | — | US | disclosed |
| US-8334301-B2 | 5-Membered heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-12-18 | — | — | US | disclosed |
| WO-2012162742-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2012-12-06 | — | — | WO | disclosed |
| US-20120309787-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | ST. VINCENT'S INSTITUTE OF MEDICAL RESEARCH (AU) | 2012-12-06 | — | — | US | disclosed |
| EP-1789079-B1 | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof | FLOREY HOWARD INST (AU) | 2012-11-07 | — | — | EP | disclosed |
| WO-2012146940-A2 | METHOD OF DIAGNOSIS AND PROGNOSIS | IMPERIAL INNOVATIONS LIMITED (GB) | 2012-11-01 | — | — | WO | disclosed |
| US-20120277164-A1 | GADD45BETA TARGETING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2012-11-01 | — | — | US | disclosed |
| US-8299261-B2 | 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-10-30 | — | — | US | disclosed |
| WO-2012142670-A1 | NUCLEAR MAGNETIC RESONANCE AGENT | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-10-26 | — | — | WO | disclosed |
| US-8293812-B2 | Containing thermoplastic resin having solid particles dispersed throughout; controlling particle size; modulus; high tensile strength | The University of Queensland St. Lucia (AU) | 2012-10-23 | — | — | US | disclosed |
| WO-2012139164-A1 | POLYMER CONJUGATED PROSTAGLANDIN ANALOGUES | POLYACTIVA PTY LTD (AU) | 2012-10-18 | — | — | WO | disclosed |
| EP-2507322-A1 | WATER SWELLABLE POLYMER MATERIALS | The University Of Sydney (AU) | 2012-10-10 | — | — | EP | disclosed |
| EP-2507280-A1 | POLYMERIC MATERIALS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2012-10-10 | — | — | EP | disclosed |
| US-20120252967-A1 | POLYURETHANES | GRAINS RESEARCH AND DEVELOPMENT CORPORATION (AU) | 2012-10-04 | — | — | US | disclosed |
| US-8273403-B2 | Generation of surface coating diversity | BIO-LAYER PTY LTD. (AU) | 2012-09-25 | — | — | US | disclosed |
| US-20120238706-A1 | POLYMERIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-09-20 | — | — | US | disclosed |
| US-8263775-B2 | Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof | HOWARD FLOREY INSTITUTE (AU) | 2012-09-11 | — | — | US | disclosed |
| EP-2491051-A2 | GADD45BETA TARGETING AGENTS | Imperial Innovations Limited (GB) | 2012-08-29 | — | — | EP | disclosed |
| EP-2069830-B1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | CARL ZEISS VISION AU HOLDING (AU) | 2012-08-29 | — | — | EP | disclosed |
| US-20120202877-A1 | ANTI-INFLUENZA AGENTS | GRIFFITH UNIVERSITY (AU) | 2012-08-09 | — | — | US | disclosed |
| EP-2478011-A1 | FLUORINATED GHRH ANTAGONISTS | University of Miami (US) | 2012-07-25 | — | — | EP | disclosed |
| US-8227421-B2 | Fluorinated GHRH antagonists | UNIVERSITY OF MIAMI (US) | 2012-07-24 | — | — | US | disclosed |
| US-8227405-B2 | Fluorinated GHRH antagonists | UNIVERSITY OF MIAMI (US) | 2012-07-24 | — | — | US | disclosed |
| EP-2327692-B1 | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | TAKEDA PHARMACEUTICAL (JP) | 2012-07-18 | — | — | EP | disclosed |
| US-20120165370-A1 | QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2012-06-28 | — | — | US | disclosed |
| WO-2012083866-A1 | QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2012-06-28 | — | — | WO | disclosed |
| US-20120128743-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2012-05-24 | — | — | US | disclosed |
| EP-2454248-A1 | ANTI -INFLUENZA AGENTS | Griffith University (AU) | 2012-05-23 | — | — | EP | disclosed |
| US-8173606-B2 | Sulfated oligosaccharide derivatives | PROGEN PHARMACEUTICALS LIMITED (AU) | 2012-05-08 | — | — | US | disclosed |
| US-8163760-B2 | Use of pyridopyrimidine compounds in the treatment of gliomas | PRANA BIOTECHNOLOGY LIMITED (AU) | 2012-04-24 | — | — | US | disclosed |
| US-8163767-B2 | Heterocyclic Janus Kinase 3 inhibitors | ASTELLAS PHARMA INC. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20120088797-A1 | 1-HETEROCYCLYLSULFONYL, 3-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-04-12 | — | — | US | disclosed |
| WO-2012037596-A1 | CONTINUOUS FLOW POLYMERISATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-03-29 | — | — | WO | disclosed |
| US-8143304-B2 | (3-amino-1,2,3,4-tetrahydro-9 H-carbazol-9-yl)-acetic acid derivatives | ACTELION PHARMACEUTICAL LTD. (CH) | 2012-03-27 | — | — | US | disclosed |
| US-20120059047-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | VERVA PHARMACEUTICALS PTY LTD (AU) | 2012-03-08 | — | — | US | disclosed |
| EP-2421877-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | Glycan Biosciences Pty Ltd (AU) | 2012-02-29 | — | — | EP | disclosed |
| US-8106108-B2 | Ultraviolet light absorbing optical elements and compositions and methods for manufacture | CARL ZEISS VISION AUSTRALIA HOLDINGS LIMITED (AU) | 2012-01-31 | — | — | US | disclosed |
| US-20120004259-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | SPINIFEX PHARMACEUTICALS, PTY LTD (AU) | 2012-01-05 | — | — | US | disclosed |
| US-20120004381-A1 | RAFT POLYMERISATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-01-05 | — | — | US | disclosed |
| EP-2402313-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2012-01-04 | — | — | EP | disclosed |
| EP-2401304-A1 | POLYMER PARTICLES | The University Of Sydney (AU) | 2012-01-04 | — | — | EP | disclosed |
| US-20110319437-A1 | IMINOPROPENE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110318329-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | NOVARTIS AG (CH) | 2011-12-29 | — | — | US | disclosed |
| US-8084644-B2 | Agricultural pesticide; Wide variety of compounds, for example phenyl N-phenyl-3-(phenylthio)thioacrylimidate; formula X-CH=CH-C(-Y)=N-Z where X, Y and Z are variable | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20110306769-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-12-15 | — | — | US | disclosed |
| US-20110301173-A1 | 1-HETEROCYCLYLSULFONYL, 3-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-12-08 | — | — | US | disclosed |
| US-20110301174-A1 | 1-HETEROCYCLYLSULFONYL, 3-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-12-08 | — | — | US | disclosed |
| EP-2389395-A1 | RAFT POLYMERISATION | Commonwealth Scientific and Industrial Research Organisation (AU) | 2011-11-30 | — | — | EP | disclosed |
| US-20110269753-A1 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2011-11-03 | — | — | US | disclosed |
| US-8048909-B2 | Proton pump inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-2051962-B1 | (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2011-10-26 | — | — | EP | disclosed |
| EP-2379538-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | Orchid Research Laboratories Limited (IN) | 2011-10-26 | — | — | EP | disclosed |
| US-20110256644-A1 | MASKS FOR MICROLITHOGRAPHY AND METHODS OF MAKING AND USING SUCH MASKS | MICRON TECHNOLOGY, INC. (US) | 2011-10-20 | — | — | US | disclosed |
| US-20110251393-A1 | HELICENE DERIVATIVE, AXIALLY ASYMMETRIC AMINO ACID, AMINE OR AMINOALCOHOL DERIVATIVE, PERYLENE DERIVATIVE OR SALT THEREOF, AND METHODS FOR PRODUCING SAME | KYOTO UNIVERSITY (JP) | 2011-10-13 | — | — | US | disclosed |
| EP-1534755-B1 | GENERATION OF SURFACE COATING DIVERSITY | BIO LAYER PTY LTD (AU) | 2011-10-12 | — | — | EP | disclosed |
| WO-2011120103-A1 | DYE-SENSITISED SOLAR CELL WITH NICKEL CATHODE | THE UNIVERSITY OF MELBOURNE (AU) | 2011-10-06 | — | — | WO | disclosed |
| US-20110243884-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | THE BIONICS INSTITUTE OF AUSTRALIA (AU) | 2011-10-06 | — | — | US | disclosed |
| EP-1787991-B1 | PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE | TAKEDA PHARMACEUTICAL (JP) | 2011-10-05 | — | — | EP | disclosed |
| EP-2364979-A1 | Pyrrole compounds | Takeda Pharmaceutical Company Limited (JP) | 2011-09-14 | — | — | EP | disclosed |
| EP-2363419-A1 | Polymer product formed using raft agent | The University of Sydney (AU) | 2011-09-07 | — | — | EP | disclosed |
| EP-2357177-A1 | HELICENE DERIVATIVE, AXIALLY ASYMMETRIC AMINO ACID, AMINE OR AMINOALCOHOL DERIVATIVE, PERYLENE DERIVATIVE OR SALT THEREOF, AND METHODS FOR PRODUCING SAME | Kyoto University (JP) | 2011-08-17 | — | — | EP | disclosed |
| EP-2355853-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | The Bionic Ear Institute (AU) | 2011-08-17 | — | — | EP | disclosed |
| US-20110196088-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2011-08-11 | — | — | US | disclosed |
| US-7994096-B2 | Method for antigen-specific stimulation of T lymphocytes with synthetic peptide libraries | KERN FLORIAN | 2011-08-09 | — | — | US | disclosed |
| US-20110190233-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES PTY LTD (AU) | 2011-08-04 | — | — | US | disclosed |
| US-20110190566-A1 | POLYMER MICROGEL BEADS | UNIVERSITY OF SYDNEY (AU) | 2011-08-04 | — | — | US | disclosed |
| US-7985862-B2 | Iminopyridine derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-07-26 | — | — | US | disclosed |
| US-7985863-B2 | Iminopyridine derivatives and uses thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-07-26 | — | — | US | disclosed |
| US-7982044-B2 | Iminopyridine derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7977488-B2 | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20110166298-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL ORGANISATION (AU) | 2011-07-07 | — | — | US | disclosed |
| EP-2340271-A1 | POLYMER-BIOACTIVE AGENT CONJUGATES | The Bionic Ear Institute (AU) | 2011-07-06 | — | — | EP | disclosed |
| EP-2336107-A2 | Proton pump inhibitors | Takeda Pharmaceutical Company Limited (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-20110144161-A1 | 1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-06-16 | — | — | US | disclosed |
| US-20110136988-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | Commonwealth Scientific an dIndustrial Research Organisation (AU) | 2011-06-09 | — | — | US | disclosed |
| WO-2011066616-A1 | POLYMERIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-06-09 | — | — | WO | disclosed |
| WO-2011066608-A1 | WATER SWELLABLE POLYMER MATERIALS | THE UNIVERSITY OF SYDNEY (AU) | 2011-06-09 | — | — | WO | disclosed |
| US-20110130354-A1 | SULFATED OLIGOSACCHARIDE DERIVATIVES | PROGEN PHARMACEUTICALS LIMITED (AU) | 2011-06-02 | — | — | US | disclosed |
| US-20110129417-A1 | ADMINISTRABLE COMPOSITIONS | UNIVERSITY OF SYDNEY (AU) | 2011-06-02 | — | — | US | disclosed |
| EP-2327692-A1 | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | Takeda Pharmaceutical Company Limited (JP) | 2011-06-01 | — | — | EP | disclosed |
| US-20110124875-A1 | IMINOPYRIDINE DERIVATIVES AND USES THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20110124874-A1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20110124876-A1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20110124687-A1 | PHARMACEUTICAL COMPOSITION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20110118533-A1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | UNIVERSITY OF SYDNEY (AU) | 2011-05-19 | — | — | US | disclosed |
| EP-2316824-A1 | (3-Amino-1,2,3,4-tetrahydro-9H-carbazoI-9-yl)-acetic acid derivates | Actelion Pharmaceuticals Ltd. (CH) | 2011-05-04 | — | — | EP | disclosed |
| WO-2011048390-A2 | GADD45BETA TARGETING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2011-04-28 | — | — | WO | disclosed |
| EP-2309985-A2 | PHARMACEUTICAL COMPOSITION | Takeda Pharmaceutical Company Limited (JP) | 2011-04-20 | — | — | EP | disclosed |
| EP-1919865-B1 | 1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | TAKEDA PHARMACEUTICAL (JP) | 2011-04-06 | — | — | EP | disclosed |
| WO-2011034976-A1 | FLUORINATED GHRH ANTAGONISTS | UNIVERSITY OF MIAMI (US) | 2011-03-24 | — | — | WO | disclosed |
| US-20110066230-A1 | Fluorinated GHRH Antagonists | UNIVERSITY OF MIAMI (GU) | 2011-03-17 | — | — | US | disclosed |
| EP-2291175-A1 | ADMINISTRABLE COMPOSITIONS | THE UNIVERSITY OF SYDNEY (AU) | 2011-03-09 | — | — | EP | disclosed |
| EP-2288374-A2 | NOVEL N-AND C-TERMINAL SUBSTITUTED ANTAGONISTIC ANALOGS OF HUMAN GH-RH | The University of Miami (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-2285882-A1 | POLYMER MICROGEL BEADS | THE UNIVERSITY OF SYDNEY (AU) | 2011-02-23 | — | — | EP | disclosed |
| EP-2285881-A1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | THE UNIVERSITY OF SYDNEY (AU) | 2011-02-23 | — | — | EP | disclosed |
| US-20110039892-A1 | IMINOPYRIDINE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20110039846-A1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20110034464-A1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20110028476-A1 | PROTON PUMP INHIBITORS | KAJINO MASAHIRO | 2011-02-03 | — | — | US | disclosed |
| US-20110021563-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE (AU) | 2011-01-27 | — | — | US | disclosed |
| US-7875592-B2 | inhibitors of heparan sulfate-binding proteins and inhibitors of the enzyme heparanase; antiangiogenic, antimetastatic, anti-inflammatory, antimicrobial, anticoagulant and/or antithrombotic treatment, lowering of blood triglyceride levels and inhibition of cardiovascular disease | PROGEN PHARMACEUTICALS LIMITED (AU) | 2011-01-25 | — | — | US | disclosed |
| WO-2011006208-A1 | ANTI -INFLUENZA AGENTS | GRIFFITH UNIVERSITY (AU) | 2011-01-20 | — | — | WO | disclosed |
| EP-2271624-A1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2011-01-12 | — | — | EP | disclosed |
| EP-2269989-A1 | IMINOPYRIDINE DERIVATIVE AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2011-01-05 | — | — | EP | disclosed |
| EP-2265661-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | Commonwealth Scientific and Industrial Research Organisation (AU) | 2010-12-29 | — | — | EP | disclosed |
| EP-2265654-A1 | POLYURETHANES | Commonwealth Scientific and Industrial Research Organisation (AU) | 2010-12-29 | — | — | EP | disclosed |
| EP-2262797-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | Howard Florey Institute (AU) | 2010-12-22 | — | — | EP | disclosed |
| US-20100292159-A1 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFLAMMATORY PAIN | UNIVERSITY OF QUEENSLAND (AU) | 2010-11-18 | — | — | US | disclosed |
| EP-2251341-A1 | Heterocyclic Janus kinase 3 inhibitors | Astellas Pharma Inc. (JP) | 2010-11-17 | — | — | EP | disclosed |
| US-7828840-B2 | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists | MED INSTITUTE, INC. (US) | 2010-11-09 | — | — | US | disclosed |
| US-7829580-B2 | Cyclic amine derivative having heteroaryl ring | SANKYO COMPANY, LTD. (JP) | 2010-11-09 | — | — | US | disclosed |
| EP-1916889-B1 | METHODS OF ALTERING POPPY CHARACTERISTICS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2010-11-03 | — | — | EP | disclosed |
| WO-2010118471-A1 | REACTOR AND METHOD FOR PERFORMING A CHEMICAL REACTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-10-21 | — | — | WO | disclosed |
| US-7795275-B2 | Method of treatment or prophylaxis | UNIQUEST PTY LIMITED (AU) | 2010-09-14 | — | — | US | disclosed |
| US-20100227975-A1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIVERSITY OF SYDNEY (AU) | 2010-09-09 | — | — | US | disclosed |
| WO-2010096867-A1 | POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2010-09-02 | — | — | WO | disclosed |
| US-20100210696-A1 | 5-MEMBERED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-08-19 | — | — | US | disclosed |
| WO-2010091465-A1 | POLYMER PARTICLES | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-08-19 | — | — | WO | disclosed |
| US-20100190830-A1 | (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives | ACTELION PHARMACEUTICALS LTD. (CH) | 2010-07-29 | — | — | US | disclosed |
| WO-2010083569-A1 | RAFT POLYMERISATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2010-07-29 | — | — | WO | disclosed |
| WO-2010084402-A2 | HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | ORCHID RESEARCH LABORATORIES LTD. (IN) | 2010-07-29 | — | — | WO | disclosed |
| US-7750155-B2 | Pyrazinyl hydroxyacrylamide compounds having an inhibitory effect on the activity of histone deacetylase | ASTELLAS PHARMA INC. (JP) | 2010-07-06 | — | — | US | disclosed |
| US-7745553-B2 | Aqueous dispersions of polymer particles | UNIVERSITY OF SYDNEY (AU) | 2010-06-29 | — | — | US | disclosed |
| WO-2010040188-A9 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | THE BIONIC EAR INSTITUTE (AU) | 2010-06-17 | — | — | WO | disclosed |
| EP-2196459-A1 | 5-MEMBERED HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2010-06-16 | — | — | EP | disclosed |
| EP-2190822-A2 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2010-06-02 | — | — | EP | disclosed |
| US-20100104546-A1 | MODULATORS OF ANTIGEN-DEPENDENT T CELL PROLIFERATION | CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE (AU) | 2010-04-29 | — | — | US | disclosed |
| US-20100092539-A1 | Fluorinated GHRH Antagonists | UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2010-04-15 | — | — | US | disclosed |
| WO-2010040187-A1 | POLYMER-BIOACTIVE AGENT CONJUGATES | THE BIONIC EAR INSTITUTE (AU) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010040188-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | THE BIONIC EAR INSTITUTE (AU) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010037179-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GLYCAN BIOSCIENCES PTY LTD (AU) | 2010-04-08 | — | — | WO | disclosed |
| EP-2172491-A1 | Polymer obtained by the use of RAFT-agents and process of encapsulating of particulate material by said polymer. | The University of Sydney (AU) | 2010-04-07 | — | — | EP | disclosed |
| EP-1755373-B1 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2010-03-24 | — | — | EP | disclosed |
| US-20100069393-A1 | METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME | PRANA BIOTECHNOLOGY LIMITED (AU) | 2010-03-18 | — | — | US | disclosed |
| US-20100069388-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2010-03-18 | — | — | US | disclosed |
| WO-2010020008-A1 | POLYMER COATINGS | POLYMERS CRC LIMITED (AU) | 2010-02-25 | — | — | WO | disclosed |
| US-20100048750-A1 | VESICULATED POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2010-02-25 | — | — | US | disclosed |
| US-20100041787-A1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | CARL ZEISS VISION AUSTRALIA HOLDINGS LIMITED (AU) | 2010-02-18 | — | — | US | disclosed |
| WO-2010013823-A2 | PHARMACEUTICAL COMPOSITION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-02-04 | — | — | WO | disclosed |
| WO-2009155657-A1 | CONDUCTING AND SEMICONDUCTING ORGANIC MATERIALS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-12-30 | — | — | WO | disclosed |
| WO-2009149496-A1 | TREATMENT OF DIABETES AND COMPLICATIONS THEREOF AND RELATED DISORDERS | CENTRAL NORTHERN ADELAIDE HEALTH SERVICE (AU) | 2009-12-17 | — | — | WO | disclosed |
| US-20090306059-A1 | CYCLIC AMINE DERIVATIVE HAVING SUBSTITUTED ALKYL GROUP | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-2120916-A1 | MODULATORS OF ANTIGEN-DEPENDENT T CELL PROLIFERATION | Children, Youth and Womens's Health Service Incorporated (AU) | 2009-11-25 | — | — | EP | disclosed |
| WO-2009137889-A1 | POLYMER MICROGEL BEADS | THE UNIVERSITY OF SYDNEY (AU) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009137890-A1 | ADMINISTRABLE COMPOSITIONS | THE UNIVERSITY OF SYDNEY (AU) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009137888-A1 | POLYMER MICROGEL BEADS AND PREPARATIVE METHOD THEREOF | THE UNIVERSITY OF SYDNEY (AU) | 2009-11-19 | — | — | WO | disclosed |
| US-7619091-B2 | Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052) | PRANA BIOTECHNOLOGY LIMITED (AU) | 2009-11-17 | — | — | US | disclosed |
| EP-2114917-A2 | PYRROLE COMPOUNDS | Takeda Pharmaceutical Company Limited (JP) | 2009-11-11 | — | — | EP | disclosed |
| US-20090275591-A1 | 1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITOR | TAKEDA PHARMACEUTICAL COMPANY LIMTED (JP) | 2009-11-05 | — | — | US | disclosed |
| WO-2009131245-A1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-10-29 | — | — | WO | disclosed |
| US-20090270393-A1 | Iminopyridine Derivatives and Use Thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-10-29 | — | — | US | disclosed |
| WO-2009127012-A1 | POLYURETHANES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009127009-A1 | CONDENSATION POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009127011-A1 | MODIFIED CONDENSATION POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009127010-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | disclosed |
| US-20090264399-A1 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2009-10-22 | — | — | US | disclosed |
| US-20090258979-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2009-10-15 | — | — | US | disclosed |
| WO-2009120831-A2 | NOVEL N-AND C-TERMINAL SUBSTITUTED ANTAGONISTIC ANALOGS OF GH-RH | THE UNIVERSITY OF MIAMI (US) | 2009-10-01 | — | — | WO | disclosed |
| WO-2009111830-A1 | CONJUGATED UNSATURATED COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-09-17 | — | — | WO | disclosed |
| EP-2099756-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | Astellas Pharma Inc. (JP) | 2009-09-16 | — | — | EP | disclosed |
| EP-1581535-B3 | PYRROLOPYRIDAZINE DERIVATIVES | ASTELLAS PHARMA INC (JP) | 2009-09-02 | — | — | EP | disclosed |
| EP-1838714-A4 | METHODS OF TREATING PAIN | UNIV QUEENSLAND (AU) | 2009-09-02 | — | — | EP | disclosed |
| EP-1802662-A4 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | UNIV SYDNEY (AU) | 2009-08-26 | — | — | EP | disclosed |
| EP-1539700-B1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LTD (AU) | 2009-08-26 | — | — | EP | disclosed |
| WO-2009041705-A9 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL (JP) | 2009-08-13 | — | — | WO | disclosed |
| US-20090177267-A1 | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2009-07-09 | — | — | US | disclosed |
| US-7557118-B2 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2009-07-07 | — | — | US | disclosed |
| US-7557127-B2 | HDAC inhibitor | ASTELLAS PHARMA INC. (JP) | 2009-07-07 | — | — | US | disclosed |
| EP-1651662-A4 | ANTAGONISTIC ANALOGS OF GH-RH (2003) | UNIV TULANE (US) | 2009-07-01 | — | — | EP | disclosed |
| US-20090156642-A1 | 5-Membered heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-18 | — | — | US | disclosed |
| EP-2069830-A1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | Carl Zeiss Vision Australia Holdings Ltd. (AU) | 2009-06-17 | — | — | EP | disclosed |
| US-20090149444-A1 | Benzylamine analogues | BTG INTERNATIONAL LIMITED (GB) | 2009-06-11 | — | — | US | disclosed |
| US-20090143417-A1 | METHODS OF TREATING PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2009-06-04 | — | — | US | disclosed |
| US-20090143444-A1 | ACID SECRETION INHIBITOR | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-04 | — | — | US | disclosed |
| WO-2009065169-A1 | INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE (AU) | 2009-05-28 | — | — | WO | disclosed |
| EP-2059496-A1 | ACETYLENIC COMPOUNDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2009-05-20 | — | — | EP | disclosed |
| EP-2051962-A1 | (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2009-04-29 | — | — | EP | disclosed |
| EP-2044026-A1 | METHOD OF TREATMENT OF GLIOMA BRAIN TUMOUR | Prana Biotechnology Limited (AU) | 2009-04-08 | — | — | EP | disclosed |
| US-7514475-B2 | Benzylamine analogues | BTG INTERNATIONAL LIMITED (GB) | 2009-04-07 | — | — | US | disclosed |
| WO-2009041705-A2 | 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-02 | — | — | WO | disclosed |
| US-20090075822-A1 | Method of Altering the Alkaloid Composition in Poppy Plants | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2009-03-19 | — | — | US | disclosed |
| US-7504437-B2 | Benzylamine analogues | BTG INTERNATIONAL LIMITED (GB) | 2009-03-17 | — | — | US | disclosed |
| US-7504393-B2 | Benzylamine analogues | BTG INTERNATIONAL LIMITED (GB) | 2009-03-17 | — | — | US | disclosed |
| EP-1916889-A4 | METHODS OF ALTERING POPPY CHARACTERISTICS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2009-03-11 | — | — | EP | disclosed |
| US-7498337-B2 | Acid secretion inhibitor | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20090054464-A1 | HDAC INHIBITOR | ASTELLAS PHARMA INC. (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090054482-A1 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2009-02-26 | — | — | US | disclosed |
| WO-2009024095-A1 | METHOD OF MAKING AND ADMINISTERING QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2009-02-26 | — | — | WO | disclosed |
| US-20090054465-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | ASTELLA PHARMA INC. (JP) | 2009-02-26 | — | — | US | disclosed |
| WO-2009006668-A1 | MODULATORS OF ANTIGEN-DEPENDENT T CELL PROLIFERATION | CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE (AU) | 2009-01-15 | — | — | WO | disclosed |
| WO-2009009554-A1 | AZO COLOURANT | HUNTSMAN CORPORATION AUSTRALIA PTY LIMITED (AU) | 2009-01-15 | — | — | WO | disclosed |
| US-20090010996-A1 | Human antibiotic proteins | PLANTON GMBH (DE) | 2009-01-08 | — | — | US | disclosed |
| EP-1149075-B1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS | COMMW SCIENT IND RES ORG (AU) | 2008-12-31 | — | — | EP | disclosed |
| WO-2009000049-A1 | INTRINSICALLY CONDUCTING POLYMERS | CRC SMARTPRINT PTY LTD (AU) | 2008-12-31 | — | — | WO | disclosed |
| EP-2001911-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | The University of Sydney (AU) | 2008-12-17 | — | — | EP | disclosed |
| US-7465731-B2 | HDAC inhibitor | ASTELLAS PHARMA INC. (JP) | 2008-12-16 | — | — | US | disclosed |
| EP-1569928-A4 | THERAPEUTIC COMPOUNDS AND METHODS | GOVERNMENT OF THE STATE OF SAR (MY) | 2008-12-10 | — | — | EP | disclosed |
| WO-2008144822-A1 | HOLOGRAPHIC RECORDING MEDIUM | ADVANCED POLYMERIK PTY LTD (AU) | 2008-12-04 | — | — | WO | disclosed |
| EP-1996183-A1 | METHOD OF TREATMENT OR PROPHYLAXIS INFLAMMATORY PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-12-03 | — | — | EP | disclosed |
| US-7459451-B2 | e.g. 1-Ethyl-4-(5-methyl-3-pyridyl)-6-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid; phosphodiesterase (PDE)-IV inhibitor or tumor necrosis factor (TNF)- alpha antagonist; autoimmune diseases, antidepressant, anxiolytic agent; polychondritis, scleroderma, fibrosis, arthritis, Alzheimer's disease | ASTELLAS PHARMA INC. (JP) | 2008-12-02 | — | — | US | disclosed |
| EP-1763528-B1 | PYRAZOLOPYRIDINE DERIVATIVES | ASTELLAS PHARMA INC (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-7452865-B2 | Antagonistic analogs of GH RH (2003) | THE ADMINISTRARE'S OF THE TULANE EDUCATIONAL FUND (US) | 2008-11-18 | — | — | US | disclosed |
| US-20080281016-A1 | Polymer Composite | MILLER WASTE MILLS INC. DBA RTP COMPANY | 2008-11-13 | — | — | US | disclosed |
| US-20080269058-A1 | Methods of Altering Poppy Characteristics | SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (AU) | 2008-10-30 | — | — | US | disclosed |
| US-20080268250-A1 | Polymerisation Process and Polymer Product | THE UNIVERSITY OF SYDNEY (AU) | 2008-10-30 | — | — | US | disclosed |
| US-20080262042-A1 | 1-[5-(2-Fluoropyridin-3-yl)-1-(phenylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine or a salt thereof; acid secretion inhibitor; potassium-competitive acid blocker | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1981877-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | Astellas Pharma Inc. (JP) | 2008-10-22 | — | — | EP | disclosed |
| US-20080255095-A1 | Benzylamine analogues | BTG INTERNATIONAL LIMITED (GB) | 2008-10-16 | — | — | US | disclosed |
| EP-1363880-A4 | SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS | UNIV AUSTRALIAN (AU) | 2008-10-08 | — | — | EP | disclosed |
| WO-2008108380-A2 | PYRROLE COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-12 | — | — | WO | disclosed |
| US-7419781-B1 | Human antibiotic proteins | PLANTON GMBH (DE) | 2008-09-02 | — | — | US | disclosed |
| EP-1957459-A2 | IMINOPROPENE COMPOUND AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2008-08-20 | — | — | EP | disclosed |
| US-20080194636-A1 | Enzyme Inhibitors and Uses Thereof | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2008-08-14 | — | — | US | disclosed |
| US-20080161353-A1 | 8-Hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LIMITED (AU) | 2008-07-03 | — | — | US | disclosed |
| WO-2008075757-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2008-06-26 | — | — | WO | disclosed |
| US-20080139639-A1 | 3-amino(alkyl)-substituted pyrrole compounds such as N-methyl-1-[1-(phenylsulfonyl)-5-(3-thienyl)-1H-pyrrol-3-yl]methanamine; peptic ulcer, Zollinger-Ellison syndrome, gastritis, gastroesophageal reflux disease, gastric cancer, ulcer caused by non-steroidal anti-inflammatory agent (NSAID) use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1919865-A1 | 1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2008-05-14 | — | — | EP | disclosed |
| EP-1916889-A1 | METHODS OF ALTERING POPPY CHARACTERISTICS | Glaxosmithkline Australia PTY Ltd. (AU) | 2008-05-07 | — | — | EP | disclosed |
| EP-1755373-A4 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY (AU) | 2008-05-07 | — | — | EP | disclosed |
| WO-2008046155-A1 | METHODS FOR REGULATING GLUCOSE HOMEOSTASIS AND AGENTS THEREFOR | DIA-B TECH LIMITED (AU) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008046156-A1 | VESICULATED POLYMER PARTICLES | THE UNIVERSITY OF SYDNEY (AU) | 2008-04-24 | — | — | WO | disclosed |
| EP-1910358-A2 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | Astellas Pharma Inc. (JP) | 2008-04-16 | — | — | EP | disclosed |
| EP-1366015-A4 | BENZENE-1 2-DIOL MANNICH BASES LIGANDS POLYMERS AND METHOD OF SELECTIVE METAL IONS REMOVAL | TECH RESOURCES PTY LTD (AU) | 2008-03-26 | — | — | EP | disclosed |
| US-7348382-B2 | Polyvinyl alcohol based block copolymer and pigment dispersion aqueous liquid using the same and recording liquid | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-03-25 | — | — | US | disclosed |
| WO-2008031157-A1 | ACETYLENIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2008-03-20 | — | — | WO | disclosed |
| EP-1720889-A4 | SULFATED OLIGOSACCHARIDE DERIVATIVES | PROGEN PHARMACEUTICALS LTD (AU) | 2008-03-19 | — | — | EP | disclosed |
| EP-1581535-B9 | PYRROLOPYRIDAZINE DERIVATIVES | ASTELLAS PHARMA INC (JP) | 2008-03-19 | — | — | EP | disclosed |
| WO-2008028217-A1 | ULTRAVIOLET LIGHT ABSORBING OPTICAL ELEMENTS AND COMPOSITIONS AND METHODS FOR MANUFACTURE | CARL ZEISS VISION AUSTRALIA HOLDINGS LIMITED (AU) | 2008-03-13 | — | — | WO | disclosed |
| EP-1889835-A1 | CYCLIC AMINE DERIVATIVE HAVING SUBSTITUTED ALKYL GROUP | Daiichi Sankyo Company, Limited (JP) | 2008-02-20 | — | — | EP | disclosed |
| WO-2008017989-A1 | (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2008-02-14 | — | — | WO | disclosed |
| EP-1206937-B1 | NITROIMIDAZOLE EXTERNAL PREPARATIONS FOR THE TREATMENT OF ATOPIC DERMATITIS | SHOEI CO LTD (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-7317009-B2 | Pyrrolopyridazine derivatives | ASTELLAS PHARMA INC. (JP) | 2008-01-08 | — | — | US | disclosed |
| WO-2007147217-A1 | METHOD OF TREATMENT OF GLIOMA BRAIN TUMOUR | PRANA BIOTECHNOLOGY LIMITED (AU) | 2007-12-27 | — | — | WO | disclosed |
| US-20070293532-A1 | Pyrrolo [2,3-C] Pyridine Compound, Process for Producing the Same, and Use | TAKEDA PHARMACEUTICAL COMPAN6Y LIMITED (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1362844-B1 | BENZYLAMINE ANALOGUE | BTG INT LTD (GB) | 2007-12-05 | — | — | EP | disclosed |
| EP-1581535-B1 | PYRROLOPYRIDAZINE DERIVATIVES | ASTELLAS PHARMA INC (JP) | 2007-10-24 | — | — | EP | disclosed |
| WO-2007112503-A1 | POLYMER PRODUCT AND INTERFACIAL POLYMERISATION PROCESS USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2007-10-11 | — | — | WO | disclosed |
| EP-1838714-A1 | METHODS OF TREATING PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-10-03 | — | — | EP | disclosed |
| WO-2007106938-A1 | METHOD OF TREATMENT OR PROPHYLAXIS INFLAMMATORY PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-09-27 | — | — | WO | disclosed |
| EP-1303520-B1 | THERAPEUTIC COMPOUNDS AND METHODS | GOVERNMENT OF THE STATE OF SAR (MY) | 2007-09-26 | — | — | EP | disclosed |
| EP-1830869-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-09-12 | — | — | EP | disclosed |
| WO-2007095696-A1 | POLYKETIDE XANTHONES AND USES THEREOF | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007091703-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2007-08-16 | — | — | WO | disclosed |
| US-20070185037-A1 | Sulfated oligosaccharide derivatives | PROGEN INDUSTRIES LIMITED (AU) | 2007-08-09 | — | — | US | disclosed |
| US-7253194-B2 | Compounds and inhibitors of phospholipases | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-08-07 | — | — | US | disclosed |
| EP-1803709-A1 | PROTON PUMP INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2007-07-04 | — | — | EP | disclosed |
| EP-1802662-A1 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | The University of Sydney (AU) | 2007-07-04 | — | — | EP | disclosed |
| WO-2007063702-A2 | IMINOPROPENE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-06-07 | — | — | WO | disclosed |
| EP-1789079-A1 | ENZYME INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2007-05-30 | — | — | EP | disclosed |
| EP-1787991-A1 | PYRROLOÝ2,3-c¨PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Pharmaceutical Company Limited (JP) | 2007-05-23 | — | — | EP | disclosed |
| US-7217706-B2 | Propanolamine derivatives | ASTELLAS PHARMA INC. (JP) | 2007-05-15 | — | — | US | disclosed |
| EP-1334092-B1 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | UNIV MONASH (AU) | 2007-05-09 | — | — | EP | disclosed |
| EP-1776357-A1 | HYDROXYAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF HISTONE DEACETYLASE (HDAC) | Astellas Pharma Inc. (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-7199139-B2 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2007-04-03 | — | — | US | disclosed |
| WO-2007033409-A1 | PHOTOELECTRIC MATERIALS AND PHOTOVOLTAIC CELLS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2007-03-29 | — | — | WO | disclosed |
| EP-1763528-A1 | PYRAZOLOPYRIDINE DERIVATIVES | Astellas Pharma Inc. (JP) | 2007-03-21 | — | — | EP | disclosed |
| EP-1483253-A4 | AN ANTIMICROBIAL AGENT | UNIV GRIFFITH (AU) | 2007-03-21 | — | — | EP | disclosed |
| US-20070060623-A1 | antiulcer agents; proton pump inhibitors; side effect reduction; 1-[4-fluoro-5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine; superior acid secretion inhibitory effect; peptic ulcer, Zollinger-Ellison syndrome, reflux esophagitis, or symptomatic gastroesophageal reflux disease | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-03-15 | — | — | US | disclosed |
| WO-2007026916-A1 | 1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007022561-A1 | METHODS OF ALTERING POPPY CHARACTERISTICS | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2007-03-01 | — | — | WO | disclosed |
| EP-1755373-A1 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | Glaxosmithkline Australia PTY Ltd. (AU) | 2007-02-28 | — | — | EP | disclosed |
| US-20070042950-A1 | Antagonistic analogs of gh rh (2003) | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, THE (US) | 2007-02-22 | — | — | US | disclosed |
| US-20070037795-A1 | 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders | BTG INTERNATIONAL LIMITED (GB) | 2007-02-15 | — | — | US | disclosed |
| US-20070037793-A1 | 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders | BTG INTERNATIONAL LIMITED (GB) | 2007-02-15 | — | — | US | disclosed |
| WO-2007007919-A2 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006135973-A1 | SMALL MOLECULE GLYCOSAMINOGLYCAN MIMETICS | PROGEN INDUSTRIES LIMITED (AU) | 2006-12-28 | — | — | WO | disclosed |
| US-7153854-B2 | Pyrrolopyridazine derivatives | ASTELLAS PHARMA INC. (JP) | 2006-12-26 | — | — | US | disclosed |
| US-20060270678-A1 | Pyrrolopyridazine derivatives | ASTELLAS PHARMA INC. (JP) | 2006-11-30 | — | — | US | disclosed |
| US-20060270706-A1 | Cyclic amine derivative having heteroaryl ring | SANKYO COMPANY, LTD. (JP) | 2006-11-30 | — | — | US | disclosed |
| WO-2006122344-A1 | POLYMERISATION AGENT | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2006-11-23 | — | — | WO | disclosed |
| EP-1720889-A1 | SULFATED OLIGOSACCHARIDE DERIVATIVES | Progen Industries Limited (AU) | 2006-11-15 | — | — | EP | disclosed |
| US-7135493-B2 | HDAC inhibitor | ASTELLAS PHARMA INC. (JP) | 2006-11-14 | — | — | US | disclosed |
| US-7122699-B2 | Process for preparing organic boronic acid derivatives using diboronic acid | BORON MOLECULAR LIMITED (AU) | 2006-10-17 | — | — | US | disclosed |
| US-7122694-B2 | Hydroboronation process | BORON MOLECULAR PTY LIMITED (AU) | 2006-10-17 | — | — | US | disclosed |
| US-7122673-B2 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2006-10-17 | — | — | US | disclosed |
| US-20060229236-A1 | Cyclic tetrapeptide compound and use thereof | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2006-10-12 | — | — | US | disclosed |
| US-20060223741-A1 | Method of treatment or prophylaxis | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-10-05 | — | — | US | disclosed |
| US-20060223936-A1 | Polymerization of a dispersion having a continuous aqueous phase and a dispersed organic phase of an unsaturated monomer(s), and an amphiphilic RAFT agent, which is an addition polymer residue capped with a compound containing a dithio ester or a trithiocarbonate group; paint, filler, adhesive, seals | UNIVERSITY OF SYDNEY (AU) | 2006-10-05 | — | — | US | disclosed |
| EP-1354602-B1 | MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT | SANKYO CO (JP) | 2006-10-04 | — | — | EP | disclosed |
| US-7112565-B2 | Stabilized pharmaceutical composition in lyophilized form | ASTELLAS PHARMA INC. (JP) | 2006-09-26 | — | — | US | disclosed |
| EP-1695962-A1 | CYCLIC AMINE DERIVATIVE HAVING HETEROARYL RING | Sankyo Company, Limited (JP) | 2006-08-30 | — | — | EP | disclosed |
| EP-1695716-A2 | Medicinal compositions containing diuretics and insulin sensitizers | Sankyo Company, Limited (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20060165714-A1 | Peptides for vaccination against human CMV | KERN 1 PATENTE GMBH (DE) | 2006-07-27 | — | — | US | disclosed |
| EP-1133522-B1 | ANTAGONISTIC ANALOGS OF GH-RH INHIBITING IGF-I AND -II | UNIV TULANE (US) | 2006-07-05 | — | — | EP | disclosed |
| WO-2006066362-A1 | METHODS OF TREATING PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006066361-A1 | METHOD OF TREATMENT OR PROPHYLAXIS | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-06-29 | — | — | WO | disclosed |
| EP-1539700-A4 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LTD (AU) | 2006-06-28 | — | — | EP | disclosed |
| EP-1664071-A1 | NOVEL SULFENAMIDE OXIDES | GRIFFITH UNIVERSITY (AU) | 2006-06-07 | — | — | EP | disclosed |
| EP-1664072-A1 | NOVEL SULFENAMIDES | GRIFFITH UNIVERSITY (AU) | 2006-06-07 | — | — | EP | disclosed |
| EP-1463765-A4 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIV SYDNEY (AU) | 2006-05-10 | — | — | EP | disclosed |
| US-7041442-B1 | Peptides for vaccinating against human CMV | KERN 1 PATENTE GMBH (DE) | 2006-05-09 | — | — | US | disclosed |
| EP-1651662-A2 | ANTAGONISTIC ANALOGS OF GH-RH (2003) | The Administrators of the Tulane Educational Fund (US) | 2006-05-03 | — | — | EP | disclosed |
| US-20060089423-A1 | Polyvinyl alcohol based block copolymer and pigment dispersion aqueous liquid using the same and recording liquid | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-04-27 | — | — | US | disclosed |
| US-20060089380-A1 | 8-Hydroxy quinoline derivatives | PRANA BIOTECHNOLOGY LTD. (AU) | 2006-04-27 | — | — | US | disclosed |
| US-20060083858-A1 | Generation of surface coating diversity | ANTEO TECHNOLOGIES PTY LTD (AU) | 2006-04-20 | — | — | US | disclosed |
| WO-2006037185-A1 | NOVEL SULFENAMIDES AND SULFENAMIDE OXIDES | GRIFFITH UNIVERSITY (AU) | 2006-04-13 | — | — | WO | disclosed |
| WO-2006037161-A1 | SURFACE POLYMERISATION PROCESS AND POLYMER PRODUCT USING RAFT AGENT | THE UNIVERSITY OF SYDNEY (AU) | 2006-04-13 | — | — | WO | disclosed |
| US-7026281-B1 | Antagonistic analogs of GH-RH inhibiting IGF-I and -II | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2006-04-11 | — | — | US | disclosed |
| US-7019000-B1 | Method of treating a disease condition caused or exacerbated by an HPV | INSTITUTE OF MOLECULAR & CELL BIOLOGY (SG) | 2006-03-28 | — | — | US | disclosed |
| WO-2006026832-A1 | ENZYME INHIBITORS AND USES THEREOF | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2006-03-16 | — | — | WO | disclosed |
| US-7012142-B2 | Process for preparation of bicyclic and polycyclic molecules | MONASH UNIVERSITY (AU) | 2006-03-14 | — | — | US | disclosed |
| US-20060052599-A1 | HDAC inhibitor | ASTELLAS PHARMA INC. (JP) | 2006-03-09 | — | — | US | disclosed |
| WO-2006024068-A1 | POLYMER COMPOSITE | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006016680-A1 | HYDROXYAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF HISTONE DEACETYLASE (HDAC) | ASTELLAS PHARMA INC. (JP) | 2006-02-16 | — | — | WO | disclosed |
| EP-1621533-A1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2006-02-01 | — | — | EP | disclosed |
| WO-2006007634-A1 | PROCESSES AND INTERMEDIATES | CERYLID BIOSCIENCES LTD (AU) | 2006-01-26 | — | — | WO | disclosed |
| US-20060014702-A1 | Antimicrobial agent | GRIFFITH UNIVERSITY (AU) | 2006-01-19 | — | — | US | disclosed |
| EP-1207161-B1 | NOVEL ISOINDOLE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2006-01-18 | — | — | EP | disclosed |
| WO-2006004188-A1 | PYRAZOLOPYRIDINE DERIVATIVES | ASTELLAS PHARMA INC. (JP) | 2006-01-12 | — | — | WO | disclosed |
| WO-2006004191-A1 | PYRROLOPYRIDAZINE DERIVATIVES WHICH INHIBIT PDE IV AND TNF ALFA | ASTELLAS PHARMA INC. (JP) | 2006-01-12 | — | — | WO | disclosed |
| US-20060004003-A1 | Pyrazolopyridine derivatives | ASTELLAS PHARMA INC. (JP) | 2006-01-05 | — | — | US | disclosed |
| US-20050288339-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2005-12-29 | — | — | US | disclosed |
| EP-1609807-A1 | POLYVINYL ALCOHOL BLOCK COPOLYMER AND AQUEOUS PIGMENT DISPERSIONS AND RECORDING FLUIDS MADE BY USING THE SAME | Mitsubishi Chemical Corporation (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | VERVA PHARMACEUTICALS PTY LTD (AU) | 2005-12-22 | — | — | US | disclosed |
| EP-0993463-B1 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | BORON MOLECULAR PTY LTD (AU) | 2005-11-30 | — | — | EP | disclosed |
| US-20050261177-A1 | Compound | ASTELLAS PHARMA INC. (JP) | 2005-11-24 | — | — | US | disclosed |
| WO-2005107436-A1 | METHOD OF ALTERING THE ALKALOID COMPOSITION IN POPPY PLANTS | GLAXOSMITHKLINE AUSTRALIA PTY LTD (AU) | 2005-11-17 | — | — | WO | disclosed |
| EP-0981517-B1 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES | UNIV AUSTRALIAN (AU) | 2005-11-16 | — | — | EP | disclosed |
| EP-1585735-A1 | HYDROXAMID ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | Astellas Pharma Inc. (JP) | 2005-10-19 | — | — | EP | disclosed |
| EP-1581535-A1 | PYRROLOPYRIDAZINE DERIVATIVES | Astellas Pharma Inc. (JP) | 2005-10-05 | — | — | EP | disclosed |
| WO-2005085264-A1 | SULFATED OLIGOSACCHARIDE DERIVATIVES | PROGEN INDUSTRIES LIMITED (AU) | 2005-09-15 | — | — | WO | disclosed |
| EP-1112250-A4 | THERAPEUTIC COMPOUNDS AND METHODS | INST OF MOLECUL & CELL BIOLOGY (SG) | 2005-09-14 | — | — | EP | disclosed |
| EP-1569928-A1 | THERAPEUTIC COMPOUNDS AND METHODS | The Government of the State of Sarawak, Malaysia (MY) | 2005-09-07 | — | — | EP | disclosed |
| US-6939985-B1 | covalently coupling organic compounds by reacting an aromatic ring compound having a halogen or halogen-like substituent at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a base | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2005-09-06 | — | — | US | disclosed |
| US-20050181988-A1 | Echinocandin cyclic peptide derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| EP-1534755-A4 | GENERATION OF SURFACE COATING DIVERSITY | BIO LAYER PTY LTD (AU) | 2005-08-17 | — | — | EP | disclosed |
| WO-2005065686-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | ADIPOGEN PHARMACEUTICALS PTY LIMITED (AU) | 2005-07-21 | — | — | WO | disclosed |
| EP-1309552-A4 | COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES | UNIV QUEENSLAND (AU) | 2005-07-20 | — | — | EP | disclosed |
| US-20050154004-A1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | AUSTRALIAN NATIONAL UNIVERSITY, THE (AU) | 2005-07-14 | — | — | US | disclosed |
| US-6911469-B2 | Sulfonamide compounds and pharmaceutical use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-06-28 | — | — | US | disclosed |
| US-20050130221-A1 | Synthesis for the preparation of compounds for screening as potential tubulin binding agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2005-06-16 | — | — | US | disclosed |
| EP-1539700-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | Prana Biotechnology Ltd (AU) | 2005-06-15 | — | — | EP | disclosed |
| US-20050124559-A1 | Antimicrobial agent | UNIVERSITY, MONASH (AU) | 2005-06-09 | — | — | US | disclosed |
| EP-1019414-B1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMW SCIENT IND RES ORG (AU) | 2005-06-08 | — | — | EP | disclosed |
| EP-1121365-B1 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2005-06-08 | — | — | EP | disclosed |
| US-20050119461-A1 | Novel receptor, and compounds which bind thereto | THE UNIVERSITY OF MELBOURNE | 2005-06-02 | — | — | US | disclosed |
| EP-1534755-A1 | GENERATION OF SURFACE COATING DIVERSITY | Bio-Layer Pty Limited (AU) | 2005-06-01 | — | — | EP | disclosed |
| US-6890934-B2 | Sulfonamide compounds and uses thereof as medicines | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-10 | — | — | US | disclosed |
| US-6884868-B1 | Cyclic hexapeptides having antibiotic activity | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-04-26 | — | — | US | disclosed |
| US-6884774-B2 | Cyclic hexapeptide derivatives | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2005-04-26 | — | — | US | disclosed |
| EP-1259535-B1 | CYCLIC HEXAPEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2005-04-13 | — | — | EP | disclosed |
| US-20050075342-A1 | Pyrrolopyridazine derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-04-07 | — | — | US | disclosed |
| US-6875740-B1 | Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2005-04-05 | — | — | US | disclosed |
| EP-1303520-A4 | THERAPEUTIC COMPOUNDS AND METHODS | GOVERNMENT OF THE STATE OF SAR (MY) | 2005-03-30 | — | — | EP | disclosed |
| WO-2005019236-A1 | NOVEL SULFENAMIDE OXIDES | GRIFFITH UNIVERSITY (AU) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005019237-A1 | NOVEL SULFENAMIDES | GRIFFITH UNIVERSITY (AU) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005016953-A2 | ANTAGONISTIC ANALOGS OF GH-RH (2003) | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (A NOT FOR PROFIT CORPORATION) (US) | 2005-02-24 | — | — | WO | disclosed |
| US-20050043358-A1 | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2005-02-24 | — | — | US | disclosed |
| EP-1506213-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2005-02-16 | — | — | EP | disclosed |
| US-20050014685-A1 | New compound | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
| WO-2005005463-A1 | ANTIFUNGAL CYCLIC LIPOPEPTIDES | ASTELLAS PHARMA INC. (JP) | 2005-01-20 | — | — | WO | disclosed |
| US-20050009834-A1 | Azole compounds, process for preparation of the same and use thereof | SUMITOMO CHEMICAL TAKEDA AGRO COMPANY, LIMITED (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20050004014-A1 | Fungicides, microbiocides; glucanase inhibitor; prophylaxis, therapy for pneumocystis infections in humans, animals | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1127060-B8 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2005-01-05 | — | — | EP | disclosed |
| EP-1000108-B1 | AQUEOUS POLYIMIDE PROCESS | COMMW SCIENT IND RES ORG (AU) | 2005-01-05 | — | — | EP | disclosed |
| WO-2004113368-A1 | CYCLIC LIPOPEPTIDES | ASTELLAS PHARMA INC. (JP) | 2004-12-29 | — | — | WO | disclosed |
| EP-1483253-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2004-12-08 | — | — | EP | disclosed |
| US-20040229889-A1 | HDAC inhibitor | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-18 | — | — | US | disclosed |
| WO-2004096766-A1 | A METHOD OF INDOLE SYNTHESIS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2004-11-11 | — | — | WO | disclosed |
| EP-1107777-B1 | STABILIZED PHARMACEUTICAL COMPOSITION IN LYOPHILIZED FORM | FUJISAWA PHARMACEUTICAL CO (JP) | 2004-10-27 | — | — | EP | disclosed |
| EP-1463765-A1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | University of Sydney (AU) | 2004-10-06 | — | — | EP | disclosed |
| EP-1458746-A2 | CYCLIC TETRAPEPTIDE COMPOUND AND USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6794529-B2 | CATALYTIC REACTION OF DIBORANE COMPOUND USING GROUP 8 METAL CATALYST | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-09-21 | — | — | US | disclosed |
| US-20040180947-A1 | hypoglycemic activity or phoshodiesterase-V inhibitory activity; prophylaxis and treatment of impaired glucose tolerance disorder, diabetes (e.g., type II diabetes), diabetic complications | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-09-16 | — | — | US | disclosed |
| WO-2004072047-A1 | INDOLES, BENZIMIDAZOLES OR NAPHHIMIDAZOLES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-26 | — | — | WO | disclosed |
| WO-2004071401-A2 | HYDROXAMIC ACID DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS (HDCA) | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-26 | — | — | WO | disclosed |
| US-6777410-B2 | SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20040157769-A1 | Stabilized pharmaceutical composition in lyophilized form | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
| EP-1334092-A4 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | UNIV MONASH (AU) | 2004-08-11 | — | — | EP | disclosed |
| US-6774104-B1 | CYCLIC POLYPEPTIDE STABILIZED WITH LACTOSE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-10 | — | — | US | disclosed |
| WO-2004065334-A1 | METHOD OF REMOVING ORGANOTIN RESIDUE | CHIROGEN PTY LIMITED (AU) | 2004-08-05 | — | — | WO | disclosed |
| WO-2004065335-A1 | ENANTIOSELECTIVE REDUCTION METHOD | CHIROGEN PTY LIMITED (AU) | 2004-08-05 | — | — | WO | disclosed |
| WO-2004065411-A2 | PEPTIDES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2004-08-05 | — | — | WO | disclosed |
| WO-2004063169-A1 | HYDROXAMID ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2004-07-29 | — | — | WO | disclosed |
| WO-2004063197-A1 | PYRROLOPYRIDAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-07-29 | — | — | WO | disclosed |
| US-20040138488-A1 | Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal | TECHNOLOGICAL RESOURCES PTY LTD. (AU) | 2004-07-15 | — | — | US | disclosed |
| US-20040133028-A1 | Hydroboronation process | COMMONWEALTH SCIENTIFIC | 2004-07-08 | — | — | US | disclosed |
| US-20040110727-A1 | Aldehyde-releasing compounds | LA TROBE UNIVERSITY (AU) | 2004-06-10 | — | — | US | disclosed |
| US-20040106159-A1 | Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries | KERN FLORIAN (DE) | 2004-06-03 | — | — | US | disclosed |
| WO-2004041812-A1 | THERAPEUTIC COMPOUNDS AND METHODS | THE GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2004-05-21 | — | — | WO | disclosed |
| US-20040092436-A1 | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| US-20040082757-A1 | Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs | ASTELLAS PHARMA INC. (JP) | 2004-04-29 | — | — | US | disclosed |
| US-6727245-B2 | 4-(HETERO)ARYL-3-OXO-3,4-DIHYDROPYRIDO(2,3-B)PYRAZINE DERIVATIVES; PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PHOSPHODIESTERASE IV AND TUMOR NECROSIS FACTOR MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-04-27 | — | — | US | disclosed |
| WO-2004031198-A1 | ENANTIOSELECTIVE REDUCTIVE METHODS USING CHIRAL ORGANOSTANNANES | CHIROGEN PTY LIMITED (AU) | 2004-04-15 | — | — | WO | disclosed |
| US-20040067981-A1 | Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants | SANKYO COMPANY, LIMITED (JP) | 2004-04-08 | — | — | US | disclosed |
| EP-1127060-B1 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2004-04-07 | — | — | EP | disclosed |
| US-6713566-B1 | CATALYTIC HYDROBORATION OF OLEFINIC OR ACETYLENIC FUNCTIONA-LIZED MATERIAL UNDER MILD CONDITIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-03-30 | — | — | US | disclosed |
| US-6710075-B2 | COMPOUNDS HAVING A CYCLOPENTABENZOFURAN CORE SHOWN TO EXHIBIT POTENT CYTOTOXIC AND CYTOSTATIC EFFECTS ON CANCER CELL GROWTH AND VIABILITY | THE GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2004-03-23 | — | — | US | disclosed |
| US-20040053923-A1 | Novel isoindole derivatives | BANYU PHARMACEUTICAL CO., LTD. | 2004-03-18 | — | — | US | disclosed |
| US-20040053974-A1 | Medicinal compositions containing diuretic and insulin resistance-improving agent | SANKYO COMPANY, LIMITED (JP) | 2004-03-18 | — | — | US | disclosed |
| WO-2003097657-A9 | AN ANTIMICROBIAL AGENT | UNIV GRIFFITH (AU) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004018487-A1 | CHIRAL ORGANOSILICON HYDRIDES | CHIROGEN PTY LIMITED (AU) | 2004-03-04 | — | — | WO | disclosed |
| US-6696611-B2 | Chemical methods | CHIROGEN PTY. LIMITED (AU) | 2004-02-24 | — | — | US | disclosed |
| US-20040033995-A1 | Compounds and inhibitors of phospholipases | QUEENSLAND, THE UNIVERSITY OF (AU) | 2004-02-19 | — | — | US | disclosed |
| WO-2004011473-A1 | ORGANOGERMANIUM COMPOUNDS AND METHODS FOR THEIR USE | CHIROGEN PTY LIMITED (AU) | 2004-02-05 | — | — | WO | disclosed |
| EP-1386915-A1 | AZOLE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-02-04 | — | — | EP | disclosed |
| WO-2004007461-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PRANA BIOTECHNOLOGY LIMITED (AU) | 2004-01-22 | — | — | WO | disclosed |
| EP-1382333-A2 | Use of beta 3 adrenergic receptor agonists in the treatment of dysuria | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-01-21 | — | — | EP | disclosed |
| US-6680401-B1 | BORON COMPOUNDS SUCH AS 4-(METHOXYMETHYL)-1,3,2-DIOXABOROLANE, USED AS COUPLERS OR CHEMICAL INTERMEDIATES FOR DRUGS, PESTICIDES OR IN COMBINATORIAL CHEMISTRY | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-01-20 | — | — | US | disclosed |
| US-20040010140-A1 | Process for preparation of bicyclic and polycyclic molecules | MONASH UNIVERSITY (AU) | 2004-01-15 | — | — | US | disclosed |
| US-20040002512-A1 | Alpha-substituted carboxylic acid derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-01-01 | — | — | US | disclosed |
| EP-1366015-A1 | BENZENE-1 2-DIOL MANNICH BASES LIGANDS POLYMERS AND METHOD OF SELECTIVE METAL IONS REMOVAL | TECHNOLOGICAL RESOURCES PTY. LTD. (AU) | 2003-12-03 | — | — | EP | disclosed |
| EP-1366065-A1 | ECHINOCANDIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USE THEREOF AS DRUGS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-12-03 | — | — | EP | disclosed |
| EP-1366066-A2 | CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-12-03 | — | — | EP | disclosed |
| WO-2003097657-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2003-11-27 | — | — | WO | disclosed |
| US-20030220237-A1 | Pharmaceutical composition | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2003-11-27 | — | — | US | disclosed |
| US-20030220520-A1 | Process for preparing organic boronic acid derivatives using diboronic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-11-27 | — | — | US | disclosed |
| EP-0927177-B1 | NOVEL BENZOTHIOPHENE DERIVATIVES, THEIR PREPARATION AND USE AS UROKINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-11-26 | — | — | EP | disclosed |
| EP-1363880-A1 | SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2003-11-26 | — | — | EP | disclosed |
| WO-2003095494-A1 | GENERATION OF SURFACE COATING DIVERSITY | BIO-LAYER PTY LIMITED (AU) | 2003-11-20 | — | — | WO | disclosed |
| EP-1362844-A1 | BENZYLAMINE ANALOGUE | Sankyo Company, Limited (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-20030208076-A1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | AUSTRALIAN NATIONAL UNIVERSITY, THE (AU) | 2003-11-06 | — | — | US | disclosed |
| EP-1354602-A1 | MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT | Sankyo Company, Limited (JP) | 2003-10-22 | — | — | EP | disclosed |
| EP-1149075-A4 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | DU PONT (US) | 2003-10-22 | — | — | EP | disclosed |
| US-20030181514-A1 | Therapeutic compounds and methods | GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2003-09-25 | — | — | US | disclosed |
| US-20030171396-A1 | Sulfonamide compounds and uses thereof as medicines | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
| US-20030166979-A1 | Catalytic reduction using hydrogen | DAKTERNIEKS DAINIS (AU) | 2003-09-04 | — | — | US | disclosed |
| WO-2003070715-A1 | AN ANTIMICROBIAL AGENT | GRIFFITH UNIVERSITY (AU) | 2003-08-28 | — | — | WO | disclosed |
| WO-2003068807-A2 | ECHINOCANDIN CYCLIC PEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-08-21 | — | — | WO | disclosed |
| US-6608098-B1 | Diabetes or obesity, 2-(4-(3-isopropyl-2,5-dioxo-2,3-dihydro-1H-pyrrolo(2,1-a) isoindol-9(5H)-yl)phenoxy)-N-propylacetamide | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2003-08-19 | — | — | US | disclosed |
| EP-1334092-A1 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | Monash University (AU) | 2003-08-13 | — | — | EP | disclosed |
| US-6603004-B2 | Reacting diboron tetrahydroxide with boronic acid derivatives in presence of group 8-11 metal catalyst; one pot; no need for hydrolysis or hydrogenolysis | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-08-05 | — | — | US | disclosed |
| US-6596751-B2 | An insulin resistance improving agent, hypoglycemic agent, immunoregulatory agent, aldose reductase inhibitor, 5-lipoxygenase inhibitor, peroxidized lipid production suppressor, PPAR. activator, leukotriene antagonist, adipose | SANKYO COMPANY LIMITED (JP) | 2003-07-22 | — | — | US | disclosed |
| WO-2003057722-A2 | CYCLIC TETRAPEPTIDE COMPOUND AND USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-17 | — | — | WO | disclosed |
| WO-2003055919-A1 | AQUEOUS DISPERSIONS OF POLYMER PARTICLES | UNIVERSITY OF SYDNEY (AU) | 2003-07-10 | — | — | WO | disclosed |
| EP-0914340-B1 | hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY | UNIV TULANE (US) | 2003-07-09 | — | — | EP | disclosed |
| US-20030114638-A1 | Alkene borates and a process for covalently coupling organic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-06-19 | — | — | US | disclosed |
| US-20030114488-A1 | New processes for producing beta-alanine derivatives | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2003-06-19 | — | — | US | disclosed |
| US-6573274-B1 | Treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| US-20030092754-A1 | External preparation for skin diseases containing nitroimidazole | SHOEI CO., LTD. (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-1309552-A1 | COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES | THE UNIVERSITY OF QUEENSLAND (AU) | 2003-05-14 | — | — | EP | disclosed |
| US-6559310-B2 | Reacting a halogen aromatic derivative at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a suitable base for covalently coupling organic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-05-06 | — | — | US | disclosed |
| US-20030083238-A1 | Cyclic hexapeptide derivatives | ASTELLAS PHARMA INC. (JP) | 2003-05-01 | — | — | US | disclosed |
| EP-1303520-A1 | THERAPEUTIC COMPOUNDS AND METHODS | The Government of the State of Sarawak, Malaysia (MY) | 2003-04-23 | — | — | EP | disclosed |
| US-20030069294-A1 | Alpha-substituted carboxylic acid derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-04-10 | — | — | US | disclosed |
| WO-2003028739-A2 | COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA OR HYPERGLYCEMIA COMPRISING A POLYMER OR ITS SALT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-04-10 | — | — | WO | disclosed |
| EP-0799220-B1 | POLYMERISABLE MONOMERS AND POLYMERS | COMMW SCIENT IND RES ORG (AU) | 2003-04-09 | — | — | EP | disclosed |
| US-6538007-B1 | Hydrates and method of antogonizing glycoprotein IIb/IIIa activity using these compounds is also disclosed. antagonist, inhibitor of blood platelets aggregation and inhibitor of the binding of fibrinogen to blood platelets. | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-03-25 | — | — | US | disclosed |
| US-6521757-B1 | Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2003-02-18 | — | — | US | disclosed |
| US-6521643-B1 | Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-02-18 | — | — | US | disclosed |
| US-20030032838-A1 | Substituted diboron compounds | BORON MOLECULAR PTY LIMITED (AU) | 2003-02-13 | — | — | US | disclosed |
| EP-0770079-B1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-02-12 | — | — | EP | disclosed |
| US-6515160-B2 | Boronic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-02-04 | — | — | US | disclosed |
| US-6512081-B1 | Synthesis of dithioester chain transfer agents and use of bis(thioacyl) disulfides or dithioesters as chain transfer agents | E.I. DUPONT NEMOURS AND COMPANY | 2003-01-28 | — | — | US | disclosed |
| US-20030017975-A1 | Use | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1056751-A4 | BORONIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2003-01-22 | — | — | EP | disclosed |
| US-6506925-B2 | Synthesis from haloalkenes or pseudo-haloalkenes | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2003-01-14 | — | — | US | disclosed |
| US-20030009030-A1 | Novel selective deacetylating agents | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-01-09 | — | — | US | disclosed |
| EP-1090008-A4 | SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES | UNIV AUSTRALIAN (AU) | 2003-01-02 | — | — | EP | disclosed |
| US-20020193604-A1 | Aryl borates | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-12-19 | — | — | US | disclosed |
| US-6495546-B1 | SUCH AS 1-(N-BENZYL-N-(3-METHOXY-6,7,8,9-TETRAHYDRO-5H-BENZO-CYCLOHEPTEN-6-YL)AMINO)-3-PHENOXY-2-PROPANOL; ADRENERGIC RECEPTOR AGONISTS; ANTIULCEROUS, LIPOLYTIC, ANTIURINARY INCONTINENCE AND ANTIPOLLAKIURIA ACTIVITIES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| US-6495643-B1 | RING OPENING POLYMERIZATION OF SUCH AS 6-METHYLENE-1,4-DITHIEPANE OPTIONALLY WITH METHYL METHACRYLATE; MINIMIZING SHRINKAGE; HIGH MOLECULAR WEIGHT; SUCH AS AMIDE, ESTER OR CARBONATE BACKBONE GROUPS; ADHESIVES, COMPOSITES, LENSES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2002-12-17 | — | — | US | disclosed |
| EP-1259535-A1 | CYCLIC HEXAPEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-27 | — | — | EP | disclosed |
| US-6469171-B1 | NON-TOXIC MODULATORS OF THE MULTIDRUG RESISTANT PHENOTYPE | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20020151743-A1 | Process for preparing organic boronic avid derivatives using diboronic acid | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-10-17 | — | — | US | disclosed |
| US-20020143034-A1 | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2002-10-03 | — | — | US | disclosed |
| EP-1245550-A1 | NOVEL SELECTIVE DEACETYLATING AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-10-02 | — | — | EP | disclosed |
| WO-2002072621-A2 | CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-09-19 | — | — | WO | disclosed |
| US-20020133039-A1 | Chemical methods | DEAKIN UNIVERSITY (AU) | 2002-09-19 | — | — | US | disclosed |
| EP-1239868-A2 | USE OF AN IMMUNOSUPPRESSANT FOR INCREASING AN ANTIFUNGAL ACTIVITY OF A LIPOPETIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-09-18 | — | — | EP | disclosed |
| WO-2002070456-A1 | BENZENE-1 2-DIOL MANNICH BASES LIGANDS POLYMERS AND METHOD OF SELECTIVE METAL IONS REMOVAL | TECHNOLOGICAL RESOURCES PTY LIMITED (AU) | 2002-09-12 | — | — | WO | disclosed |
| US-6448433-B1 | REACTING AN ORGANIC HALIDE WITH TETRAHYDROXYDIBORON; GROUP 8-11 METAL CATALYST | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2002-09-10 | — | — | US | disclosed |
| WO-2002068456-A1 | ECHINOCANDIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USE THEREOF AS DRUGS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-09-06 | — | — | WO | disclosed |
| US-20020120148-A1 | Propanolamine derivatives | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2002-08-29 | — | — | US | disclosed |
| EP-1127060-A4 | HYDROBORONATION PROCESS | COMMW SCIENT IND RES ORG (AU) | 2002-08-21 | — | — | EP | disclosed |
| EP-0986541-A4 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMW SCIENT IND RES ORG (AU) | 2002-08-14 | — | — | EP | disclosed |
| WO-2002060872-A1 | SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2002-08-08 | — | — | WO | disclosed |
| US-20020107251-A1 | Heterobicyclic derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-08-08 | — | — | US | disclosed |
| EP-1084121-B1 | OXADIAZOLINE DERIVATIVES AND THEIR USE AS INSECTICIDES | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-07-31 | — | — | EP | disclosed |
| US-6426345-B1 | PHOSPHODIESTERASE INHIBITORS; ANTIINFLAMMATORY AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-30 | — | — | US | disclosed |
| US-20020099212-A1 | For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2002-07-25 | — | — | US | disclosed |
| EP-1224190-A1 | SUBSTITUTED DIBORON COMPOUNDS | Commonwealth Scientific and Research Organisation (AU) | 2002-07-24 | — | — | EP | disclosed |
| EP-0686156-B1 | PYRAZOLITRIAZINES WITH INTERLEUKIN-1 AND TUMOUR NECROSIS FACTOR INHIBITORY ACTIVITY | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-07-17 | — | — | EP | disclosed |
| WO-2002053584-A1 | STABILIZED PHARMACEUTICAL COMPOSITION IN LYOPHILIZED FORM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-11 | — | — | WO | disclosed |
| EP-0993463-A4 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2002-06-12 | — | — | EP | disclosed |
| US-6399779-B1 | REACTING A HALOGEN AROMATIC DERIVATIVE AT A COUPLING POSITION WITH A DIBORON DERIVATIVE IN THE PRESENCE OF A GROUP 8 METAL CATALYST | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-06-04 | — | — | US | disclosed |
| EP-1019414-A4 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMW SCIENT IND RES ORG (AU) | 2002-05-29 | — | — | EP | disclosed |
| EP-1207161-A1 | NOVEL ISOINDOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| EP-1206937-A1 | NITROIMIDAZOLE EXTERNAL PREPARATIONS FOR DERMATOSIS | SHOEI CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| US-6384028-B1 | TREATMENT OF CARDIOVASCULAR DISORDERS, ANTICOAGULANTS AND VALVE REPLACEMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| US-20020052522-A1 | Boronic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION | 2002-05-02 | — | — | US | disclosed |
| WO-2002034736-A1 | PROCESS FOR PREPARATION OF BICYCLIC AND POLYCYCLIC MOLECULES | MONASH UNIVERSITY (AU) | 2002-05-02 | — | — | WO | disclosed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |
| US-6380215-B1 | FOR PREVENTION AND/OR TREATMENT OF DISEASES CAUSED BY THROMBUS FORMATION SUCH AS ARTERIAL THROMBOSIS, ARTERIAL SCLEROSIS, ISCHEMIC HEART DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2002-04-30 | — | — | US | disclosed |
| WO-2002032974-A2 | POLYMER AND ITS USE FOR THE TREATMENT AND/OR PREVENTION OF HYPERPHOSPHOREMIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002028345-A2 | ALDEHYDE-RELEASING COMPOUNDS | LA TROBE UNIVERSITY (AU) | 2002-04-11 | — | — | WO | disclosed |
| US-6362206-B1 | FUNGICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-03-26 | — | — | US | disclosed |
| US-20020032339-A1 | ARYL BORATES | BORON MOLECULAR LIMITED (AU) | 2002-03-14 | — | — | US | disclosed |
| EP-1121365-A4 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMW SCIENT IND RES ORG (AU) | 2002-03-06 | — | — | EP | disclosed |
| EP-0874845-B1 | PYRIDO (2,3-B) PYRAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-03-06 | — | — | EP | disclosed |
| WO-2002015106-A2 | PREDICTION METHOD OF A 3D STRUCTURE OF A TRANSMEMBRANE PROTEIN | RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) | 2002-02-21 | — | — | WO | disclosed |
| EP-1180038-A2 | ANTIFUNGAL COMBINATION USE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-6348474-B1 | COMPOUNDS AS ANTIDIABETIC AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-02-19 | — | — | US | disclosed |
| US-6346639-B1 | Boronic compounds | THE COMMONWEALTH OF AUSTRALIA COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 2002-02-12 | — | — | US | disclosed |
| US-6346527-B1 | 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-02-12 | — | — | US | disclosed |
| US-20020016489-A1 | Alkene borates and a process for covalently coupling organic compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION | 2002-02-07 | — | — | US | disclosed |
| US-6344556-B1 | THIO CONTAINING MONOMERS FOR POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-02-05 | — | — | US | disclosed |
| WO-2002008189-A1 | COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES | THE UNIVERSITY OF QUEENSLAND (AU) | 2002-01-31 | — | — | WO | disclosed |
| EP-1173472-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-01-23 | — | — | EP | disclosed |
| WO-2002002566-A1 | THERAPEUTIC COMPOUNDS AND METHODS | THE GOVERNMENT OF THE STATE OF SARAWAK, MALAYSIA (MY) | 2002-01-10 | — | — | WO | disclosed |
| EP-1044194-A4 | RECEPTOR WITH AN AFFINITY FOR COMPOUNDS OF THE OXAZOLINE CLASS | UNIV MELBOURNE (AU) | 2002-01-09 | — | — | EP | disclosed |
| EP-1167357-A1 | ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 2002-01-02 | — | — | EP | disclosed |
| US-6333391-B1 | FROM AMINES AND CARBOXYLIC ACIDS OR ANHYDRIDES, IN WATER; | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-12-25 | — | — | US | disclosed |
| WO-2001094348-A1 | ANTIVIRAL AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-12-13 | — | — | WO | disclosed |
| US-20010051730-A1 | Beta-alanine derivative and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-0669912-B1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-12-05 | — | — | EP | disclosed |
| EP-1157022-A1 | PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-11-28 | — | — | EP | disclosed |
| EP-1149075-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-10-31 | — | — | EP | disclosed |
| EP-1140849-A1 | AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA 3 ADRENERGIC AGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-1136492-A1 | SULFONAMIDE COMPOUNDS AND USES THEREOF AS MEDICINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-09-26 | — | — | EP | disclosed |
| US-6294536-B1 | CONTROL OF PROTOZOA AND REDUCTION IN THE INCIDENCE OF ASSOCIATED DISEASES AND DEATH AND CONSEQUENT IMPROVEMENT IN RETARDED GROWTH AND GENERAL CONDITION AND PREVENTING DECREASE GROWTH AND GENERAL CONDITION | TAKEDA SCHERING-PLOUGH ANIMAL HEALTH K.K. (JP) | 2001-09-25 | — | — | US | disclosed |
| EP-1133522-A1 | ANTAGONISTIC ANALOGS OF GH-RH INHIBITING IGF-I AND -II | The Administrators of The Tulane Educational Fund (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6288259-B1 | 1,3,2-DIOXABOROLANES OR OR DIOXABOROLANES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-09-11 | — | — | US | disclosed |
| US-6288088-B1 | SUCH AS 1-(2,6-DICHLORO-4-TRIFLUOROMETHYLPHENYL)-3-(4-( N,N-DIMETHYLCARBAMOYL)-.DELTA..SUP.2-1,2,4-OXADIAZOLIN-3-YL)-5 -ISOPROPOXYMETHYLENEAMINO-4-TRIFLUOROMETHYLSULFINYLPYRAZOLE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-09-11 | — | — | US | disclosed |
| EP-1127060-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-08-29 | — | — | EP | disclosed |
| US-20010016571-A1 | N-[ (R) -1-{3- (4- piperidyl) propionyl } -3-piperidylcarbonyl] -2 (S) -acetylamino-beta -alanine as fibrinogen receptor antagonist | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-23 | — | — | US | disclosed |
| WO-2001060846-A1 | CYCLIC HEXAPEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-23 | — | — | WO | disclosed |
| US-6274619-B1 | FUSED AMIDINO TYPE COMPOUNDS SUCH AS 4-(N-BUTYLCARBAMOYLMETHYLIDENE)-2-AMIDINO-4,5,6,7-TETRAHYDROBE NZO(B)THIOPHENE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-14 | — | — | US | disclosed |
| EP-1121346-A1 | NEW PROCESSES FOR PRODUCING BETA-ALANINE DERIVATIVE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-08 | — | — | EP | disclosed |
| EP-1121365-A1 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2001-08-08 | — | — | EP | disclosed |
| WO-2000031136-A9 | ANTAGONISTIC ANALOGS OF GH-RH INHIBITING IGF-I AND -II | UNIV TULANE (US) | 2001-07-19 | — | — | WO | disclosed |
| EP-1112250-A1 | THERAPEUTIC COMPOUNDS AND METHODS | Institute of Molecular and Cell Biology (SG) | 2001-07-04 | — | — | EP | disclosed |
| EP-1107777-A1 | STABILIZED PHARMACEUTICAL COMPOSITION IN LYOPHILIZED FORM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-20 | — | — | EP | disclosed |
| EP-0757682-B1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-06-20 | — | — | EP | disclosed |
| WO-2001041780-A2 | USE OF AN IMMUNOSUPPRESSANT FOR INCREASING AN ANTIFUGAL ACTIVITY OF A LIPOPEPTIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-14 | — | — | WO | disclosed |
| EP-1106606-A2 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |
| WO-2001029051-A1 | SUBSTITUTED DIBORON COMPOUNDS | COMMONWEALTH SCIENTIFIC AND RESEARCH ORGANISATION (AU) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001025179-A1 | PREPARATION OF TETRACYCLIC INTERMEDIATES | INSTITUTE OF DRUG TECHNOLOGY AUSTRALIA LIMITED (AU) | 2001-04-12 | — | — | WO | disclosed |
| EP-1090008-A1 | SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2001-04-11 | — | — | EP | disclosed |
| EP-1084121-A1 | OXADIAZOLINE DERIVATIVES AND THEIR USE AS INSECTICIDES | Takeda Chemical Industries, Ltd. (JP) | 2001-03-21 | — | — | EP | disclosed |
| EP-1073650-A1 | GUANIDINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-02-07 | — | — | EP | disclosed |
| EP-1070046-A1 | PROPANOLAMINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-01-24 | — | — | EP | disclosed |
| EP-0981517-A4 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | UNIV AUSTRALIAN (AU) | 2001-01-24 | — | — | EP | disclosed |
| EP-1067926-A2 | IMMUNOSUPPRESSIVE IMIDAZOLE DERIVATIVES AND THEIR COMBINATION PREPARATIONS WITH TACROLIMUS OR CYCLOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-01-17 | — | — | EP | disclosed |
| WO-2001002002-A1 | STABILIZED PHARMACEUTICAL COMPOSITION IN LYOPHILIZED FORM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-01-11 | — | — | WO | disclosed |
| WO-2000072865-A2 | ANTIFUNGAL COMBINATION USE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-07 | — | — | WO | disclosed |
| CN-1275984-A | Process for preparing organic boronic acid derivatives using diboronic acid | COMMW SCIENT IND RES ORG (AU) | 2000-12-06 | — | — | CN | disclosed |
| EP-1056751-A1 | BORONIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-12-06 | — | — | EP | disclosed |
| EP-1053247-A1 | ANTIFUNGAL CYCLOHEXAPEPTIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-22 | — | — | EP | disclosed |
| US-6150351-A | ADMINISTERING AN EFFECTIVE AMOUNT OF THE CEPHEM COMPOUND TO A PATIENT SUFFERING FROM DISEASES CAUSED BY HELICOBACTER PYLORI | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-21 | — | — | US | disclosed |
| EP-0734396-B1 | ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY | UNIV TULANE (US) | 2000-11-08 | — | — | EP | disclosed |
| WO-2000064927-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-02 | — | — | WO | disclosed |
| EP-1044194-A1 | RECEPTOR WITH AN AFFINITY FOR COMPOUNDS OF THE OXAZOLINE CLASS | THE UNIVERSITY OF MELBOURNE (AU) | 2000-10-18 | — | — | EP | disclosed |
| EP-1000108-A4 | AQUEOUS POLYIMIDE PROCESS | COMMW SCIENT IND RES ORG (AU) | 2000-10-11 | — | — | EP | disclosed |
| US-6121311-A | Method for treating cocainism | JAPAN TOBACCO INC. (JP) | 2000-09-19 | — | — | US | disclosed |
| US-6117875-A | Pyrido (2,3-B) pyrazine derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-09-12 | — | — | US | disclosed |
| WO-2000049015-A1 | PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-24 | — | — | WO | disclosed |
| US-6093710-A | AN ENZYME INHIBITOR TREATING ANGIOGENESIS, ARTHRITIS, INFLAMMATION, METASTASIS, OSTEOPOROSIS, TUMORSANGIOGENESIS-DEPENDENT RETINOPATHIES, CONTRACEPTIVE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-25 | — | — | US | disclosed |
| EP-1019414-A1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-07-19 | — | — | EP | disclosed |
| WO-2000040560-A1 | AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA 3 ADRENERGIC AGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000031136-A1 | ANTAGONISTIC ANALOGS OF GH-RH INHIBITING IGF-I AND -II | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2000-06-02 | — | — | WO | disclosed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | disclosed |
| WO-2000027853-A1 | HYDROBORONATION PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-05-18 | — | — | WO | disclosed |
| EP-1000108-A1 | AQUEOUS POLYIMIDE PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-05-17 | — | — | EP | disclosed |
| US-6057422-A | AMINO ACID SEQUENCE OF SYNTHETIC POLYPEPTIDE OF HUMAN GROWTH HORMONE-RELEASING HORMONE WHICH SUPPRESSES RELEASE OF INSULIN-LIKE GROWTH FACTORS; FOR ANTICARCINOGENIC AGENTS | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0995742-A1 | SULFONAMIDE COMPOUNDS AND MEDICINAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-26 | — | — | EP | disclosed |
| WO-2000021932-A1 | NEW PROCESSES FOR PRODUCING β-ALANINE DERIVATIVE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-20 | — | — | WO | disclosed |
| WO-2000021966-A1 | ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-04-20 | — | — | WO | disclosed |
| EP-0993463-A1 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-04-19 | — | — | EP | disclosed |
| US-6043361-A | ALLYLIC COMPOUND CONTAINING CYCLIZED SULFUR CONTAINING RINGS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-03-28 | — | — | US | disclosed |
| EP-0986541-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-03-22 | — | — | EP | disclosed |
| WO-2000014063-A1 | THERAPEUTIC COMPOUNDS AND METHODS | INSTITUTE OF MOLECULAR & CELL BIOLOGY (SG) | 2000-03-16 | — | — | WO | disclosed |
| US-6034248-A | FUNGICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-03-07 | — | — | US | disclosed |
| EP-0981517-A1 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998050365-A9 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | UNIV AUSTRALIAN (AU) | 2000-02-03 | — | — | WO | disclosed |
| US-6017917-A | Guanidine derivatives | FUJISAWA PHARAMCEUTICAL CO., LTD. (JP) | 2000-01-25 | — | — | US | disclosed |
| WO-1999067250-A1 | SYNTHESES OF A VARIETY OF LAMELLARIN COMPOUNDS AND ANALOGUES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999062903-A1 | OXADIAZOLINE DERIVATIVES AND THEIR USE AS INSECTICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999055690-A1 | GUANIDINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-11-04 | — | — | WO | disclosed |
| US-5968985-A | INHIBITORS OF SODIUM ION/HYDROGEN ION EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-19 | — | — | US | disclosed |
| WO-1999051564-A1 | PROPANOLAMINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999051215-A2 | IMMUNOSUPPRESSIVE IMIDAZOLE DERIVATIVES AND THEIR COMBINATION PREPARATIONS WITH TACROLIMUS OR CYCLOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-14 | — | — | WO | disclosed |
| EP-0946587-A2 | NEW AMIDE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-06 | — | — | EP | disclosed |
| US-5952299-A | CYCLIC PEPTIDES; ANTIFUNGAL AGENT; BETA-GLUCAN SYNTHASE INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-14 | — | — | US | disclosed |
| WO-1999040108-A1 | NEW COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-12 | — | — | WO | disclosed |
| US-5932737-A | BENZOFURANYL- OR BENZOTHIENYL-TERMINATED | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-03 | — | — | US | disclosed |
| WO-1999033845-A1 | BORONIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-07-08 | — | — | WO | disclosed |
| EP-0920867-A1 | Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-06-09 | — | — | EP | disclosed |
| WO-1999024411-A1 | RECEPTOR WITH AN AFFINITY FOR COMPOUNDS OF THE OXAZOLINE CLASS | THE UNIVERSITY OF MELBOURNE (AU) | 1999-05-20 | — | — | WO | disclosed |
| EP-0914340-A1 | hGH-RH(1-29)NH 2? ANALOGUES HAVING ANTAGONISTIC ACTIVITY | The Administrators of The Tulane Educational Fund (US) | 1999-05-12 | — | — | EP | disclosed |
| WO-1999012940-A1 | PROCESS FOR PREPARING ORGANIC BORONIC ACID DERIVATIVES USING DIBORONIC ACID | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-03-18 | — | — | WO | disclosed |
| WO-1999011634-A1 | TRIAZINE DERIVATIVES, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-11 | — | — | WO | disclosed |
| WO-1999006470-A1 | AQUEOUS POLYIMIDE PROCESS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-11 | — | — | WO | disclosed |
| WO-1999005099-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-04 | — | — | WO | disclosed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | disclosed |
| US-5858995-A | ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0888302-A1 | N- (R)-1- 3-(4-PIPERIDYL)PROPIONYL-3-PIPERIDYLCARBONYL]-2(S)-ACETYLAMINO-BETA-ALANINE AS FIBRINOGEN RECEPTOR ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-01-07 | — | — | EP | disclosed |
| WO-1998058935-A1 | ALKENE BORATES AND A PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-12-30 | — | — | WO | disclosed |
| WO-1998055475-A1 | GUANIDINE DERIVIATIVES AS INHIBITORS OF NA+/H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-12-10 | — | — | WO | disclosed |
| EP-0882052-A1 | NEW CEPHEM COMPOUNDS AND PHARMACEUTICAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| WO-1998051687-A1 | PIPERIDINO DERIVATIVES WHICH PROMOTE GROWTH HORMONE RELEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-19 | — | — | WO | disclosed |
| WO-1998050365-A1 | PREPARATION OF FUSED POLYCYCLIC ALKALOIDS BY RING CLOSURE OF AZOMETHINE YLIDES, NOVEL COMPOUNDS THEREOF AND THEIR USE AS CHEMOTHERAPEUTIC AGENTS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1998-11-12 | — | — | WO | disclosed |
| EP-0876338-A1 | GUANIDINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-11 | — | — | EP | disclosed |
| WO-1998049150-A1 | TRIAZINE DERIVATIVES, THEIR PRODUCTION AND AGROCHEMICAL COMPOSITION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-11-05 | — | — | WO | disclosed |
| EP-0874845-A1 | PYRIDO (2,3-B) PYRAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-11-04 | — | — | EP | disclosed |
| US-5824691-A | CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-20 | — | — | US | disclosed |
| WO-1998045265-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-10-15 | — | — | WO | disclosed |
| EP-0869944-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| US-5814324-A | OIL IN WATER EMULSION COMPRISING ANTIFUNGAL TRIAZOLE COMPOUND DISPERSED IN WATER WITH FATTY ACID TRIGLYCERIDE, LECITHIN EMULSIFIER | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-09-29 | — | — | US | disclosed |
| EP-0545376-B1 | Guanidino thiazoles and their use as H2-receptor antagonist | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-09-09 | — | — | EP | disclosed |
| US-5792780-A | FUNGICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0567982-B1 | Azole compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-07-01 | — | — | EP | disclosed |
| WO-1998027108-A2 | NEW AMIDE COMPOUNDS AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-25 | — | — | WO | disclosed |
| WO-1998024785-A1 | INDOLE-UREA DERIVATIVES WITH 5-HT ANTAGONIST PROPERTIES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-11 | — | — | WO | disclosed |
| EP-0799220-A4 | POLYMERISABLE MONOMERS AND POLYMERS | COMMW SCIENT IND RES ORG (AU) | 1998-04-15 | — | — | EP | disclosed |
| US-5739130-A | TREATING SYSTEMIC LUPUS ERYTHEMATOSIS, MELANOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-04-14 | — | — | US | disclosed |
| EP-0657449-B1 | Azole compounds, their production and use as antifungal agents | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-04-08 | — | — | EP | disclosed |
| EP-0831826-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-01 | — | — | EP | disclosed |
| WO-1997042223-A9 | hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY | — | 1998-03-12 | — | — | WO | disclosed |
| WO-1998006709-A1 | CYCLIC UREA COMPOUNDS, THEIR PRODUCTION AND USE AS HERBICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-02-19 | — | — | WO | disclosed |
| EP-0817796-A1 | CYCLIC PEPTIDE NUCLEI AND DERIVATIVES THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-01-14 | — | — | EP | disclosed |
| EP-0809640-A1 | AZOLE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-12-03 | — | — | EP | disclosed |
| WO-1997042223-A1 | hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 1997-11-13 | — | — | WO | disclosed |
| EP-0799220-A1 | POLYMERISABLE MONOMERS AND POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1997-10-08 | — | — | EP | disclosed |
| US-5670503-A | PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR MEDIATED DISEASES SUCH AS INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-09-23 | — | — | US | disclosed |
| WO-1997033869-A1 | N-[(R)-1-{3-(4-PIPERIDYL)PROPIONYL-3-PIPERIDYLCARBONYL]-2(S)-ACETYLAMINO-BETA-ALANINE AS FIBRINOGEN RECEPTOR ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-09-18 | — | — | WO | disclosed |
| WO-1997029111-A1 | NEW CEPHEM COMPOUNDS AND PHARMACEUTICAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-14 | — | — | WO | disclosed |
| WO-1997027183-A1 | GUANIDINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-31 | — | — | WO | disclosed |
| EP-0784612-A1 | UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-23 | — | — | EP | disclosed |
| WO-1997025310-A1 | GUANIDINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-17 | — | — | WO | disclosed |
| WO-1997024355-A1 | PYRIDO (2,3-B) PYRAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-10 | — | — | WO | disclosed |
| EP-0773927-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |
| EP-0770079-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-02 | — | — | EP | disclosed |
| US-5624931-A | Pyrazole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-29 | — | — | US | disclosed |
| US-5622976-A | NERVOUS SYSTEM DISORDERS; ALZHEIMER*S DISEASE; CEREBROVASCULAR DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-22 | — | — | US | disclosed |
| US-5616556-A | USING A CYCLIC PEPTIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| WO-1997011075-A1 | TRIAZOLE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-03-27 | — | — | WO | disclosed |
| EP-0336230-B1 | Cyclic peptide antagonists of Substance P and Substance K | FUJISAWA PHARMACEUTICAL CO (JP) | 1997-02-12 | — | — | EP | disclosed |
| EP-0757682-A1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-12 | — | — | EP | disclosed |
| WO-1996039382-A1 | UREA DERIVATIVES AS 5-HT ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996039142-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE | F. HOFFMANN-LA ROCHE AG (CH) | 1996-12-12 | — | — | WO | disclosed |
| EP-0746318-A1 | INJECTABLE EMULSIONS CONTAINING ANTIFUNGAL TRIAZOLE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 1996-12-11 | — | — | EP | disclosed |
| US-5583135-A | TREATING SYSTEMIC LUPUS ERYTHEMATOSIS OR MELANOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-10 | — | — | US | disclosed |
| WO-1996034866-A1 | IMIDAZO 1,2-A PYRIDINE AND IMIDAZO 1,2-A PYRIDEZINE DERIVATIVES AND THEIR USE AS BONE RESORPTION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-07 | — | — | WO | disclosed |
| WO-1996030399-A1 | CYCLIC PEPTIDE NUCLEI AND DERIVATIVES THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-03 | — | — | WO | disclosed |
| WO-1996029309-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-26 | — | — | WO | disclosed |
| WO-1996025410-A1 | AZOLE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-08-22 | — | — | WO | disclosed |
| US-5545652-A | Triazole and imidazole compounds and their use as antifungal therapeutic agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-08-13 | — | — | US | disclosed |
| EP-0721449-A1 | INHIBITORS OF $g(b)-AMYLOID PROTEIN PRODUCTION | MERRELL PHARMACEUTICALS INC. (US) | 1996-07-17 | — | — | EP | disclosed |
| US-5536737-A | Compound having prolyl endopeptidase inhibitory activity and pharmaceutical use thereof | JAPAN TOBACCO INC. (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5532258-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| WO-1996019471-A1 | POLYMERISABLE MONOMERS AND POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1996-06-27 | — | — | WO | disclosed |
| US-5527777-A | TREATMENT OF PROSTATE CANCER, ANTIFERTILITY AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-06-18 | — | — | US | disclosed |
| WO-1996016981-A2 | PEPTIDE COMPOUNDS FOR PREVENTION AND/OR TREATMENT OF NO-MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-06-06 | — | — | WO | disclosed |
| WO-1996010559-A1 | UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-11 | — | — | WO | disclosed |
| EP-0699185-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-03-06 | — | — | EP | disclosed |
| WO-1996005187-A1 | (4-(3-AMINOMETHYLPHENYL)THIAZOL-2-YL)-GUANIDINES AS H2-RECEPTOR ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-22 | — | — | WO | disclosed |
| WO-1996004241-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |
| WO-1996001825-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-01-25 | — | — | WO | disclosed |
| US-5478827-A | Inhibits Interleukin-1 and tumor necrosis factor production | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-12-26 | — | — | US | disclosed |
| EP-0687473-A1 | OPTICAL ISOMERIZATION INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-12-20 | — | — | EP | disclosed |
| EP-0686156-A1 | PYRAZOLITRIAZINES WITH INTERLEUKIN-1 AND TUMOUR NECROSIS FACTOR INHIBITORY ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-12-13 | — | — | EP | disclosed |
| WO-1995031202-A1 | CAGE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTIVIRAL AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1995-11-23 | — | — | WO | disclosed |
| US-5466820-A | Fungicides | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-11-14 | — | — | US | disclosed |
| WO-1995029907-A1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-11-09 | — | — | WO | disclosed |
| US-5461048-A | Tricyclic compounds having cholecystokinin antagonist activity | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-10-24 | — | — | US | disclosed |
| WO-1995024395-A1 | QUINOLINE DERIVATIVES AS IMMUNOMODULATORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-14 | — | — | WO | disclosed |
| EP-0670309-A1 | COMPOUND WITH PROLYL ENDOPEPTIDASE INHIBITOR ACTIVITY AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 1995-09-06 | — | — | EP | disclosed |
| WO-1995022973-A1 | INJECTABLE EMULSIONS CONTAINING ANTIFUNGAL TRIAZOLE DERIVATIVES | TAKEDA CHEMICALS INDUSTRIES, LTD. (JP) | 1995-08-31 | — | — | WO | disclosed |
| EP-0669334-A1 | TRICYCLIC COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-08-30 | — | — | EP | disclosed |
| WO-1995022330-A1 | ANTIVIRAL AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1995-08-24 | — | — | WO | disclosed |
| US-5436140-A | Cyclic peptides as antagonist, analgesics or antihistamines | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| WO-1995018126-A1 | FURYLTHIAZOLE AND THEIR USE AS H2-RECEPTOR ANTAGONISM AND ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-06 | — | — | WO | disclosed |
| EP-0657449-A1 | Azole compounds, their production and use as antifungal agents | Takeda Chemical Industries, Ltd. (JP) | 1995-06-14 | — | — | EP | disclosed |
| WO-1995009838-A1 | INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION | MERRELL PHARMACEUTICALS INC. (US) | 1995-04-13 | — | — | WO | disclosed |
| WO-1995008536-A1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-03-30 | — | — | WO | disclosed |
| US-5401737-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-03-28 | — | — | US | disclosed |
| EP-0639182-A1 | QUINOLINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-02-22 | — | — | EP | disclosed |
| WO-1994029295-A1 | HETEROCYCLIC DERIVATIVES WITH IMMUNOMODULATING ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-12-22 | — | — | WO | disclosed |
| US-5371101-A | Fungicides | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-12-06 | — | — | US | disclosed |
| WO-1994026709-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-24 | — | — | WO | disclosed |
| EP-0619814-A1 | OXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINIC AGONIST ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| US-5356897-A | Inhibit the production of Interleukin-1 and tumor necrosis factor; administering for treatment of chronic inflammatory diseases, autoimmune diseases and sepsis-induced organ injury | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-18 | — | — | US | disclosed |
| WO-1994020126-A1 | USE OF PEPTIDES FOR THE MANUFACTURE OF A MEDICAMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994019350-A1 | PYRAZOLITRIAZINES WITH INTERLEUKIN-1 AND TUMOUR NECROSIS FACTOR INHIBITORY ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-01 | — | — | WO | disclosed |
| US-5322842-A | Tricyclic benzodiazepine derivates, their preparation, and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-21 | — | — | US | disclosed |
| EP-0360079-B1 | Tricyclic compounds, processes for their preparation and pharmaceutical compositions comprising them | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-02-02 | — | — | EP | disclosed |
| EP-0238070-B1 | Sulfonylurea compounds, their production and herbicidal use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1993-12-29 | — | — | EP | disclosed |
| US-5273998-A | Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1993-12-28 | — | — | US | disclosed |
| EP-0567982-A1 | Azole compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1993-11-03 | — | — | EP | disclosed |
| US-5248679-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-28 | — | — | US | disclosed |
| WO-1993013083-A1 | OXADIAZOLE DERIVATIVES HAVING ACETYLCHOLINESTERASE-INHIBITORY AND MUSCARINIC AGONIST ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-08 | — | — | WO | disclosed |
| EP-0544909-A1 | TRICYCLIC BENZODIAZEPINE DERIVATES THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-09 | — | — | EP | disclosed |
| EP-0545376-A1 | Guanidino thiazoles and their use as H2-receptor antagonist | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-09 | — | — | EP | disclosed |
| US-5217952-A | Analgesics, antihistamine | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-08 | — | — | US | disclosed |
| EP-0531901-A2 | Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-5177216-A | DIASTEREOMERIC ESTER COMPOUND USEFUL AS AN INTERMEDIATE IN THE MAKING OF AN OPTICALLY ACTIVE 3,4-DIHYDRO-3,4-EPOXY-2H-1-BENZOPYRAN COMPOUND | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1993-01-05 | — | — | US | disclosed |
| US-5162553-A | Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds and intermediates therefor | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1992-11-10 | — | — | US | disclosed |
| WO-1992018483-A1 | QUINOLINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-10-29 | — | — | WO | disclosed |
| US-5155101-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1992-10-13 | — | — | US | disclosed |
| WO-1992012154-A1 | IMIDAZOTRIAZINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-07-23 | — | — | WO | disclosed |
| WO-1992003438-A1 | TRICYCLIC BENZODIAZEPINE DERIVATES THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-03-05 | — | — | WO | disclosed |
| WO-1992002513-A1 | HETEROCYCLIC COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-02-20 | — | — | WO | disclosed |
| US-5066816-A | PROCESSES FOR PREPARING OPTICALLY ACTIVE 3,4-DIHYDRO-3,4-EPOXY-2H-1-BENZOPYRAN COMPOUNDS AND INTERMEDIATES THEREFOR | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1991-11-19 | — | — | US | disclosed |
| EP-0456266-A1 | Method for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds, intermediates therefor and uses thereof | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1991-11-13 | — | — | EP | disclosed |
| US-5017212-A | For rice paddies | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| US-4981847-A | Tricyclic compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-01-01 | — | — | US | disclosed |
| EP-0386640-A2 | Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds and intermediates therefor | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1990-09-12 | — | — | EP | disclosed |
| EP-0336230-A2 | Cyclic peptide antagonists of Substance P and Substance K | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-10-11 | — | — | EP | disclosed |
| EP-0275101-A2 | Novel peptidase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-07-20 | — | — | EP | disclosed |
| US-4576753-A | MICROBIOCIDES, ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-03-18 | — | — | US | disclosed |
| US-4472309-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4304718-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-08 | — | — | US | disclosed |
| US-4264498-A | REACTED WITH AN ACID, ITS ACID HALIDE, OR ANHYDRIDE IN THE PRESENCE OF BORON TRIHALIDE AND AN ORGANIC BASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
| US-4181800-A | ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-3975532-A | ANALGESIC | ICI UNITED STATES INC. (US) | 1976-08-17 | — | — | US | disclosed |
| US-3975532-A | ANALGESIC | ICI UNITED STATES INC. (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261177-A1 | Compound | MANBA, MAN2B1, MAN2A1 | ALDH1A1 3841/4885CYP1A2 1548/4885CYP2C9 2024/4885 |
| US-20170240592-A1 | GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY | MCL1, DDIT3, MAP2K7 | ALDH1A1 2876/4885CYP1A2 3580/4885CYP2C9 4163/4885 |
| US-20070185037-A1 | Sulfated oligosaccharide derivatives | HPSE, APOB, LIPG | ALDH1A1 3329/4885CYP1A2 3833/4885CYP2C9 2448/4885 |
| US-20090054465-A1 | N-HYDROXYACRYLAMIDE COMPOUNDS | HDAC1, HDAC6, HDAC5 | ALDH1A1 266/4885CYP1A2 1690/4885CYP2C9 1723/4885 |
| US-20150368294-A1 | GADD45BETA TARGETING AGENTS | DDB1, CCL2, DDIT3 | ALDH1A1 3663/4885CYP1A2 4371/4885CYP2C9 4788/4885 |
| US-20160075716-A1 | POLYMERIC MATERIALS | PUF60, CD68, RPP30 | ALDH1A1 2346/4885CYP1A2 2307/4885CYP2C9 3360/4885 |
| US-20140031376-A1 | IMINOPROPENE COMPOUND AND USE THEREOF | IMPA1, INPP5A, CTRL | ALDH1A1 2213/4885CYP1A2 1435/4885CYP2C9 1478/4885 |
| US-20030166979-A1 | Catalytic reduction using hydrogen | GRHPR, CBR1, SPR | ALDH1A1 141/4885CYP1A2 604/4885CYP2C9 825/4885 |
| US-20060229236-A1 | Cyclic tetrapeptide compound and use thereof | NGLY1, CRH, NPY1R | ALDH1A1 4779/4885CYP1A2 4171/4885CYP2C9 4361/4885 |
| US-20090075822-A1 | Method of Altering the Alkaloid Composition in Poppy Plants | AHCY, DHPS, PAH | ALDH1A1 939/4885CYP1A2 605/4885CYP2C9 1190/4885 |
| US-20050009834-A1 | Azole compounds, process for preparation of the same and use thereof | C1S, CYP4B1, CYP4X1 | ALDH1A1 2531/4885CYP1A2 35/4885CYP2C9 75/4885 |
| US-20110190566-A1 | POLYMER MICROGEL BEADS | MSN, CD47, SMC4 | ALDH1A1 4369/4885CYP1A2 4425/4885CYP2C9 4744/4885 |
| US-20100069393-A1 | METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME | MGMT, DHFR, IDH2 | ALDH1A1 1278/4885CYP1A2 1840/4885CYP2C9 3709/4885 |
| US-20170008874-A1 | Method for Producing Sulfonyl Chloride Compound | P2RY4, P2RY6, P2RX4 | ALDH1A1 2246/4885CYP1A2 442/4885CYP2C9 97/4885 |
| US-20140163001-A1 | HETEROCYCLIC COMPOUND | RORC, RORB, RORA | ALDH1A1 202/4885CYP1A2 194/4885CYP2C9 324/4885 |
| US-20080262042-A1 | 1-[5-(2-Fluoropyridin-3-yl)-1-(phenylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine or a salt thereof; acid secretion inhibitor; potassium-competitive acid blocker | REN, HRH2, ATP4A | ALDH1A1 1650/4885CYP1A2 2093/4885CYP2C9 1954/4885 |
| US-20020016489-A1 | Alkene borates and a process for covalently coupling organic compounds | ALK, ORC3, ALKBH3 | ALDH1A1 916/4885CYP1A2 393/4885CYP2C9 360/4885 |
| US-20090143444-A1 | ACID SECRETION INHIBITOR | HRH2, VIP, CCKBR | ALDH1A1 2004/4885CYP1A2 1488/4885CYP2C9 1313/4885 |
| US-20110190233-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GNE, CD44, FUT5 | ALDH1A1 1240/4885CYP1A2 2674/4885CYP2C9 2455/4885 |
| US-20060052599-A1 | HDAC inhibitor | HDAC1, HDAC2, HDAC11 | ALDH1A1 1014/4885CYP1A2 1586/4885CYP2C9 2265/4885 |
| US-20150337128-A1 | RELEASE MEDIA | CHMP4B, CRH, GRPR | ALDH1A1 4874/4885CYP1A2 4489/4885CYP2C9 4600/4885 |
| US-20110301174-A1 | 1-HETEROCYCLYLSULFONYL, 3-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | CMA1, GIPR, CTRL | ALDH1A1 1313/4885CYP1A2 1858/4885CYP2C9 2253/4885 |
| US-20040157769-A1 | Stabilized pharmaceutical composition in lyophilized form | ADCYAP1R1, MC2R, IAPP | ALDH1A1 3307/4885CYP1A2 3485/4885CYP2C9 2092/4885 |
| US-20040002512-A1 | Alpha-substituted carboxylic acid derivatives | SLC5A1, SLC2A1, GPR119 | ALDH1A1 28/4885CYP1A2 297/4885CYP2C9 690/4885 |
| US-20170298026-A1 | ALL PURPOSE RAFT AGENT | NPC1L1, RFTN1, SGMS2 | ALDH1A1 817/4885CYP1A2 3459/4885CYP2C9 4702/4885 |
| US-20150335635-A1 | 8-HYDROXY QUINOLINE DERIVATIVES | PARK7, COQ8A, NLN | ALDH1A1 725/4885CYP1A2 177/4885CYP2C9 391/4885 |
| US-20130296350-A1 | Method of Treatment or Prophylaxis | AGTR2, AGTR1, NTSR2 | ALDH1A1 1906/4885CYP1A2 3326/4885CYP2C9 3977/4885 |
| US-20120059047-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | FGF1, FABP4, FGF2 | ALDH1A1 1103/4885CYP1A2 4682/4885CYP2C9 4885/4885 |
| US-20020099212-A1 | For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity | PDE2A, PDE3A, PDE12 | ALDH1A1 570/4885CYP1A2 1473/4885CYP2C9 2077/4885 |
| US-20210070705-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | DHPS, STS, HPD | ALDH1A1 1184/4885CYP1A2 148/4885CYP2C9 26/4885 |
| US-20080161353-A1 | 8-Hydroxy quinoline derivatives | PARK7, COQ8A, NLN | ALDH1A1 725/4885CYP1A2 177/4885CYP2C9 391/4885 |
| US-20200093852-A1 | Methods of Treating Ocular Disorders | ALDH1A2, HPSE, RB1 | ALDH1A1 2240/4885CYP1A2 4837/4885CYP2C9 4847/4885 |
| US-20030220520-A1 | Process for preparing organic boronic acid derivatives using diboronic acid | BTD, BRAP, DBF4 | ALDH1A1 1918/4885CYP1A2 486/4885CYP2C9 387/4885 |
| US-20040092436-A1 | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins | IL2, ICOS, NOS2 | ALDH1A1 2973/4885CYP1A2 93/4885CYP2C9 319/4885 |
| US-20110251393-A1 | HELICENE DERIVATIVE, AXIALLY ASYMMETRIC AMINO ACID, AMINE OR AMINOALCOHOL DERIVATIVE, PERYLENE DERIVATIVE OR SALT THEREOF, AND METHODS FOR PRODUCING SAME | AADAT, AASDHPPT, AZI2 | ALDH1A1 976/4885CYP1A2 229/4885CYP2C9 2170/4885 |
| US-20160303243-A1 | ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE | GNE, CD44, FUT5 | ALDH1A1 1240/4885CYP1A2 2674/4885CYP2C9 2455/4885 |
| US-20200115336-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | DHPS, STS, HPD | ALDH1A1 1184/4885CYP1A2 148/4885CYP2C9 26/4885 |
| US-20040229889-A1 | HDAC inhibitor | HDAC1, HDAC2, HDAC11 | ALDH1A1 401/4885CYP1A2 2548/4885CYP2C9 2924/4885 |
| US-20140046018-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | BMP2, MKI67, FGF2 | ALDH1A1 686/4885CYP1A2 3517/4885CYP2C9 4130/4885 |
| US-10100311-B2 | Fibrotic treatment | ENPEP, IL4I1, LNPEP | ALDH1A1 1064/4885CYP1A2 2822/4885CYP2C9 3866/4885 |
| US-20110034464-A1 | IMINOPYRIDINE DERIVATIVES AND USE THEREOF | ADRA1D, ADRB1, ADRB2 | ALDH1A1 33/4885CYP1A2 446/4885CYP2C9 929/4885 |
| US-20140343070-A1 | PROTON PUMP INHIBITORS | HRH2, HRH4, CYP2C19 | ALDH1A1 2529/4885CYP1A2 138/4885CYP2C9 58/4885 |
| US-20150150999-A1 | POLYMER-NSAID CONJUGATE | PTGS1, PTGES3, PTGES | ALDH1A1 216/4885CYP1A2 420/4885CYP2C9 193/4885 |
| US-20120128743-A1 | POLYMER PARTICLES | ELOC, EPN1, FASN | ALDH1A1 2713/4885CYP1A2 2727/4885CYP2C9 3231/4885 |
| US-20120202877-A1 | ANTI-INFLUENZA AGENTS | NEU1, NEU3, NEU4 | ALDH1A1 515/4885CYP1A2 1630/4885CYP2C9 3516/4885 |
| US-20180141912-A1 | VERSATILE RAFT AGENT | CNKSR1, CNR2, CNR1 | ALDH1A1 1350/4885CYP1A2 951/4885CYP2C9 3162/4885 |
| US-10308605-B2 | Proton pump inhibitors | HRH2, HRH4, HRH1 | ALDH1A1 2593/4885CYP1A2 150/4885CYP2C9 77/4885 |
| US-20110243884-A1 | BIODEGRADABLE POLYMER - BIOACTIVE MOIETY CONJUGATES | BMP2, MKI67, FGF2 | ALDH1A1 686/4885CYP1A2 3517/4885CYP2C9 4130/4885 |
| US-20140323422-A1 | Anionic Conjugates of Glycosylated Bacterial Metabolite | GNE, CD44, FUT5 | ALDH1A1 1240/4885CYP1A2 2674/4885CYP2C9 2455/4885 |
| US-20180327519-A1 | AMPHIPHILIC RAFT AGENT | RFTN1, CETP, LIPA | ALDH1A1 1321/4885CYP1A2 4346/4885CYP2C9 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.